Warning: mkdir(): Permission denied in /home/virtual/lib/view_data.php on line 81

Warning: fopen(upload/ip_log/ip_log_2024-11.txt): failed to open stream: No such file or directory in /home/virtual/lib/view_data.php on line 83

Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 84
The current condition of the workers’ general health examination in South Korea: a retrospective study
Skip Navigation
Skip to contents

Ann Occup Environ Med : Annals of Occupational and Environmental Medicine

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Ann Occup Environ Med > Volume 29; 2017 > Article
Research Article The current condition of the workers’ general health examination in South Korea: a retrospective study
Young Joong Kang, Jun-Pyo Myong, Huisu Eom, Bowha Choi, Jong Heon Park, Eun-A L Kimorcid
Annals of Occupational and Environmental Medicine 2017;29:6.
DOI: https://doi.org/10.1186/s40557-017-0157-0
Published online: March 7, 2017

Occupational Safety and Health Research Institute, Korea Occupational Safety and Health Agency, Ulsan, Republic of Korea

• Received: December 12, 2016   • Accepted: February 8, 2017

© The Author(s). 2017

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

  • 242 Views
  • 0 Download
  • 17 Web of Science
  • 16 Crossref
  • 17 Scopus
prev next
  • Background
    Business owners in the Republic of Korea must take part in the workers’ general health examination. However, there have been few formal analyses of the uptake of this examination by employees. In the present study, we examined the rates of participation in medical examinations according to age group, health insurance type, and enterprise size, and then compared these results with those of the national general health screening. Furthermore, we determined the distribution of patients with abnormal results for diabetes and hypertension, and outlined the significance and history of domestic health examinations.
  • Methods
    We started by comparing participation rates extracted from the among health examination data of the National Health Insurance Service from 2006–2013 by sex, age, insurance type, and enterprise size of workplace health insurance beneficiaries (i.e., those whose insurance is provided by their workplace). In addition, we analyzed the prevalence rates of abnormal results for hypertension and diabetes, and explored the history and significance of health examinations in the Republic of Korea.
  • Results
    The overall participation rate in the primary health examination in 2006 was 56%, and this increased to 72% in 2013. However, the rates of the secondary screening did not increase much. Among workplace policyholders (i.e., those whose insurance is provided by their workplace), the participation rates of workers in enterprises with less than 50 employees were lower than were those in enterprises with 50 or more employees. Notably, the rates and odds ratios of patients with abnormal results for diabetes and hypertension were relatively high, particularly among those working in smaller enterprises.
  • Conclusions
    Although the workers’ general health examination has been replaced with the national general health screening, it remains necessary to ensure uniform health management services among all workers in the Republic of Korea. This can, in turn, promote occupational health and improve working conditions throughout the Republic of Korea.
In the Republic of Korea, business owners are obligated to take part in the workers’ general health examination (WGHE), in accordance with the Industrial Safety and Health Act, as part of efforts to protect workers’ health. The WGHE is differentiated from the workers’ special health examination (WSHE) in that the latter comprises 178 items for workers who are regularly exposed to 177 hazardous substances and various physical environments specified by law, as well as night shift workers, whereas the former is administered to regular workers only.
However, according to an existing law, the WGHE can be substituted with the national general health screening, which is covered by National Health Insurance Service [1]; as such, unlike the WGHE and WSHE, employers do not need to pay for provision of the national general health screening. Furthermore, it is generally recognized that accessibility of the results of the WGHE is somewhat lower than is that for the results of the WSHE, as the latter results must be reported by the employer to the Korea Occupational Safety and Health Agency database, given that it is applicable only to workers with clearer risks and who are working more hazardous environments. For this reason, there has been little research interest in the WGHE in the field of occupational medicine.
As with other Korean health screening systems, there have been a number of studies concerning the national general health examination (NGHE) of the Korea's National Health Insurance Service (NHIS). However, most of them focused on the effects of this screening rather than on industrial health and workers’ health management. Furthermore, very few of these studies directly analyzed the official dataset provided by the NHIS [2, 3]. Prior studies on the evaluation of national health screening programs in Korea used simulation techniques [4, 5]. Accordingly, there has been no analysis of the actual conditions or effect of the WGHE.
The role of the WGHE, according to the Industrial Safety and Health Act, is currently played by the NGHE. Previous studies have grasped the actual conditions and effects of health examinations utilizing the national general health examination conducted by the NHIS for workplace policyholders and regional policyholders. However, although the NGHE has roughly the same items as the WGHE, the WGHE is used not only as a form of health screening nationwide but also as a means of health surveillance, which is one of the 11 basic duties that business owners have to protect concerning workers’ physical and mental health according to the Occupational Health Services Convention (C161) of the International Labor Organization [6]. Thus, we focused on analyzing and investigating aspects of this health examination in the terms of occupational medicine. More specifically, we determined the participation rates in health screenings among workers using data from the National Health Insurance Service and the prevalence of abnormal results for diabetes and hypertension, which can precede severe cardio- and cerebrovascular diseases (CCVDs). CCVDs are a major cause of death and workforce loss among workers and individuals in the general population. The prevalence of abnormal results for diabetes and hypertension were stratified by workers’ insurance type and enterprise size. Furthermore, we wanted to examine the differences in the odds of having major two chronic diseases—diabetes and hypertension—according to workers’ enterprise size, with a focus on whether having a small workplace can affect prevalence of diabetes and hypertension. Accordingly, we determined the odd ratios of diabetes and hypertension among workplace policyholders in their 40s and 50s by enterprise size.
In addition, we have attempted to discuss the Korean health screening system as a whole by reflecting on the history of health screening. We specifically consider when the concept of periodic health screening began and when Korea founded and structured the modern national general health examination system and workers’ health examination system. Furthermore, we describe how the WGHE came to be substituted with the NGHE, and other major institutional shifts in the health care system in the Republic of Korea. By doing so, we hope to contextualize the current state of health screening and look ahead to improving the occupational health care system.
Workers’ general health examination (WGHE)
The Ministry of Employment and Labor obligates business owners to provide workers with health examination service. Business owners arrange the WGHE for office workers and non-office workers not eligible for the WSHE (i.e., those exposed regularly to 177 hazardous substances and physical factors specified by the Industrial Safety and Health Act or night shift workers). As noted above, the WGHE may be substituted with the NGHE provided by the NHIS.
National general health examination (NGHE)
The NGHE is a nationwide health screening that does not merely focus on individuals with pathologic symptoms and signs; instead, it targets all health insurance beneficiaries. This health screening comprises an interview by physicians, blood lab data, urine analysis, chest radiography, and measurements of body weight, height, eyesight, and hearing ability. The NGHE includes all of the WGHE items except the urine dipstick test. Fasting glucose level and blood pressure tests, detailed questions to patients, physical measurements, eyesight and hearing tests, and chest radiographies are all included. The blood tests examine hemoglobin, total cholesterol, high-density lipoprotein cholesterol, triglycerides, and the liver enzyme test (including aspartate and alanine transaminase (AST/ALT), gamma-glutamyl transferase, serum creatinine etc.). The amount of protein in the urine is also tested. Cognitive dysfunction tests are also selectively performed for elderly people.
The National Health Insurance Service actually provides a variety of major health screening services aside from the NGHE, such as health screening for lifetime transition periods, dental health screening, cancer screenings, and infant health screenings. The NGHE service is based on health examination criteria specifically for workplace and regional policyholders. Workplace policyholders are individuals whose insurance is provided by their workplace, and include office workers (i.e., individuals working in general affairs, personnel management, administration, sales, design, etc.; in other words, workers who are not manual laborers), non-office workers (employees other than office workers), and their dependents (aged 40 or older). Regional policyholders include “owner-operators” and self-employed workers, whose insurance is provided based on their own income, and their household members (aged 40 or older). Workplace policyholders who are non-office workers receive annual health examination services, whereas regional policyholders and workplace policyholders who are office workers (along with their dependents aged 40 or older) receive health examination opportunities on a biennial basis [7].
A secondary health examination is conducted for individuals suspected of having hypertension or diabetes as well as individuals at high risk for cognitive dysfunction after the NGHE (i.e., the primary examination). This secondary examination involves more detailed questions, blood pressure measurements, and blood tests to specify the abnormal results and determine a diagnosis (e.g., of hypertension or diabetes). Individuals who were found, in either the primary or secondary examination, to require further follow-up with a physician based on suspected hypertension or diabetes were classified as “examinees with abnormal results.” These two conditions were focused on because one of the main purposes of health examinations in the Republic of Korea is prevention of CCVDs and other chronic diseases.
This study dataset was derived from the NHIS, which contains four databases: insurance qualification, medical treatment charges, national health screening program results, and medical institution data. We obtained data from the insurance qualification and NGHE databases. More specifically, information on age, sex, type of insurance, and enterprise size were extracted from the insurance qualification database. The NGHE data obtained spanned 2006 to 2013; the eligible population during this period ranged from 14 to 17 million (Table 1).
Table 1
Participation rate in primary health examination
2006 2007 2008 2009
TSa (N) Pb (n, %) TS (N) P (n, %) TS (N) P (n, %) TS (N) P (n, %)
Overall participation rate 15,053,761 8,408,218 (56%) 14,358,709 8,419,532 (59%) 16,493,801 10,264,420 (62%) 16,277,239 10,537,866 (65%)
National health insurance type
Workplace policyholder
  Non-public worker 6,138,566 4,756,163 (77%) 6,172,556 5,016,210 (81%) 7,411,510 5,953,473 (80%) 7,625,108 6,290,437 (82%)
  Office worker 1,515,523 1,078,249 (71%) 1,072,442 839,517 (78%) 2782,176 2,044,152 (73%) 2,732,174 2,049,755 (75%)
 Non-office worker 4,623,043 3,677,914 (80%) 5,100,114 4,176,693 (82%) 4,629,334 3,909,321 (84%) 4,892,934 4,240,682 (87%)
 Public official 924,071 771,830 (84%) 278,547 213,526 (77%) 900,087 779,838 (87%) 240,178 195,910 (82%)
 Dependents 2,915,863 1,383,217 (47%) 3,137,626 1,646,793 (52%) 3,380,998 1,831,665 (54%) 3,760,971 2,216,809 (59%)
Regional policyholder
 Householder 3,422,767 881,827 (26%) 3,230,823 920,406 (28%) 3,252,355 1,023,396 (31%) 3,131,656 1,113,517 (36%)
 Household member 1,652,494 615,181 (37%) 1,539,157 622,597 (40%) 1,548,851 676,048 (44%) 1,519,326 721,193 (47%)
Enterprise size (no. of employees)
  ≥ 300 3,919,021 2,825,502 (72%) 3,623,523 2,663,471 (74%) 4,210,329 3,195,498 (76%) 4,032,024 3,119,928 (77%)
 50–299 2,518,852 1,905,700 (76%) 2,299,055 1,768,735 (77%) 2,803,298 2,235,709 (80%) 2,665,965 2,125,705 (80%)
  < 50 3,540,576 2,179,986 (62%) 3,664,998 2,443,371 (67%) 4,678,882 3,133,715 (67%) 4,927,373 3,456,632 (70%)
Sex
 Male 8,345,124 4,858,065 (58%) 7,856,987 4,833,287 (62%) 8,992,965 5,763,063 (64%) 8,762,242 5,816,276 (66%)
 Female 6,708,637 3,550,153 (53%) 6,501,722 3,586,245 (55%) 7,500,836 4,501,357 (60%) 7,514,997 4,721,590 (63%)
Age
 20s 1,549,890 1,188,441 (77%) 1,457,174 1,199,391 (82%) 1,755,391 1,413,162 (81%) 1,599,916 1,305,813 (82%)
 30s 2,989,488 1,874,052 (63%) 2,652,807 1,764,649 (67%) 3,167,656 2,170,990 (69%) 2,883,761 2,014,012 (70%)
 40s 4,556,426 2,252,394 (49%) 4,256,396 2,156,367 (51%) 4,796,802 2,677,379 (56%) 4,652,757 2,744,518 (59%)
 50s 2,891,251 1,608,651 (56%) 2,826,586 1,620,394 (57%) 3,303,862 2,067,020 (63%) 3,443,763 2,235,227 (65%)
 60s 1,795,284 984,003 (55%) 1,839,183 1,081,039 (59%) 2,016,084 1,260,900 (63%) 2,097,198 1,421,468 (68%)
 70s 961,201 426,452 (44%) 1,002,204 504,698 (50%) 1,099,354 575,863 (52%) 1,202,184 692,595 (58%)
 80s 259,015 56,875 (22%) 276,871 77,305 (28%) 302,444 82,816 (27%) 339,723 104,206 (31%)
 90s 32,135 2,142 (7%) 31,629 3,063 (10%) 35,867 3,276 (9%) 39,774 4,676 (12%)
2010 2011 2012 2013
TS (N) P (n, %) TS (N) P (n, %) TS (N) P (n, %) TS (N) P (n, %)
Overall participation rate 17,039,774 11,491,730 (67%) 16,333,464 11,739,774 (72%) 16,731,040 12,083,276 (72%) 16,911,464 12,108,885 (72%)
National health insurance type
Workplace policyholder
 Non-public worker 7,707,049 6,414,938 (83%) 7,989,690 6,745,581 (84%) 8,018,933 6,578,513 (82%) 8,408,348 6,952,209 (83%)
  Office worker 2,816,343 2,088,031 (74%) 3,061,514 2,302,668 (75%) 2,975,592 2,120,013 (71%) 3,042,002 2,091,641 (69%)
  Non-office worker 4,890,706 4,326,907 (88%) 4,928,176 4,442,913 (90%) 5,043,341 4,458,500 (88%) 5,366,346 4,860,568 (91%)
 Public official 689,527 606,349 (88%) 296,912 250,506 (84%) 638,023 569,189 (89%) 325,082 281,320 (87%)
 Dependents 3,839,517 2,318,688 (60%) 3,684,603 2,444,912 (66%) 3,722,132 2,444,875 (66%) 3,860,906 2,563,906 (66%)
Regional policyholder
 Householder 3,264,589 1,350,573 (41%) 2,910,973 1,440,608 (49%) 2,895,781 1,568,840 (54%) 2,870,920 1,462,230 (51%)
 Household member 1,539,092 801,182 (52%) 1,451,286 858,167 (59%) 1,456,171 921,859 (63%) 1,446,208 849,220 (59%)
Enterprise size (no. of employees)
  ≥ 300 4,467,423 3,546,046 (79%) 4,258,740 3,482,842 (82%) 4,628,576 3,786,158 (82%) 4,549,044 3,748,268 (82%)
 50–299 2,893,594 2,371,029 (82%) 2,694,642 2,268,129 (84%) 2,927,294 2,455,925 (84%) 2,845,016 2,400,555 (84%)
  < 50 4,874,679 3,422,505 (70%) 5,017,236 3,689,450 (74%) 4,823,102 3,350,385 (69%) 5,176,526 3,625,079 (70%)
Sex
 Male 9,201,725 6,323,006 (69%) 8,814,474 6,443,675 (73%) 8,985,416 6,603,480 (73%) 9,049,455 6,613,771 (73%)
 Female 7,838,049 5,168,724 (66%) 7,518,990 5,296,099 (70%) 7,745,624 5,479,796 (71%) 7,862,009 5,495,114 (70%)
Age
 20s 1,495,971 1,232,879 82%) 1,464,287 1,245,499 (85%) 1,361,209 1,147,620 (84%) 1,260,888 1,062,788 (84%)
 30s 3,075,001 2,240,262 (73%) 2,897,369 2,213,257 (76%) 2,933,731 2,250,399 (77%) 2,764,869 2,143,148 (78%)
 40s 4,791,994 3,017,490 (63%) 4,516,171 3,071,894 (68%) 4,525,205 3,110,001 (69%) 4,684,605 3,206,437 (68%)
 50s 3,859,138 2,598,385 (67%) 3,757,946 2,710,203 (72%) 3,986,889 2,895,631 (73%) 4,080,043 2,896,439 (71%)
 60s 2,140,255 1,513,228 (71%) 2,000,631 1,517,664 (76%) 2,123,343 1,610,092 (76%) 2,224,283 1,681,885 (76%)
 70s 1,245,070 746,457 (60%) 1,263,309 815,426 (65%) 1,344,136 885,701 (66%) 1,394,240 917,989 (66%)
 80s 366,394 118,893 (32%) 364,581 136,226 (37%) 380,969 149,655 (39%) 427,317 172,632 (40%)
 90s 44,850 6,122 (14%) 45,030 7,667 (17%) 47,351 8,336 (18%) 56,214 11,183 (20%)
aTS: Total subjects
bP: Participants in health examination
To indicate the current status of the WGHE, we examined changes in the participation rates of the NGHE over the study period. Furthermore, we described the participation rates of the primary survey with those of the secondary survey, and determined the differences in general participation rates by sex, age, insurance type, and enterprise size. Regarding insurance type, the levels considered included workplace policyholders among office workers or non-office workers, dependents of workplace policyholders aged 40 or older, regional policyholders who are householders, and household members aged 40 or older. Regarding enterprise size—which was determined only among workplace policyholders—workplaces were divided according to the number of full-time employees: 300 or more, between 50 and 299, and less than 50.
After determining the proportion of examinees with abnormal results indicating either hypertension or diabetes at each workplace (abnormal results for high blood pressure and high blood glucose were determined by the physicians at the facilities where examinees had received the health examination) and determining differences in these proportions by age, insurance type, and enterprise size, we calculated the odds ratios of having hypertension or diabetes by age and enterprise size using logistic regression analysis. For the odds ratios according to enterprise size, workplaces with 300 or more employees were used as the reference. This analysis was performed to identify possible health disparities due to socioeconomic status. All statistical analyses were conducted using SAS Enterprise 4.3 (SAS Institute, Cary, NC, USA).
Distribution of primary examination participation rates
Table 1 shows the distribution of participation rates in the WGHE conducted by the National Health Insurance Service between 2006 and 2013. The total number of examinees was 15,053,761 in 2006 and 16,911,464 in 2013. Thus, an estimated 14–17 million individuals took part. In contrast, the number of participants in the NGHE was 8,408,218 in 2006 and 12,108,885 in 2013. The overall participation rates were as low as 43% in 2002 (not presented in the table), but increased thereafter, reaching 56% in 2006 and 72% in 2011 (the first point at which it exceeded 70%), at which point it leveled off (remaining 72% in 2012 and 2013).
We also observed differences in participation rates depending on insurance type, sex, and age. Regarding sex differences, the participation rate of male examinees (58%) was higher than that of female examinees (53%) in 2006. However, as the overall participation rate increased, the gap between the sexes decreased, reaching 73% and 70% among male and female examinees, respectively, in 2013.
As for age groups, the highest participation rates were observed among examinees in their 20s (77%) in 2006, followed by 30s (63%), 50s (56%), 60s (55%), 40s (49%), and 70s (44%) in that order. In 2013, the participation rates were ranked (from highest to lowest) as 20s (84%), 30s (78%), 60s (76%), 50s (71%), 40s (68%), and 70s (66%).
Regarding insurance type, workplace policyholders had the highest participation rates. In 2006, the participation rate for “non-public workers” overall was 77%. When these examinees were divided to office and non-office workers, the participation rate of non-office workers was higher, at 80%. In 2013, the participation rate of workplace policyholders was 83%, with that of non-office workers being 91%. All of these figures were higher than were those of regional policyholders, whose participation rate was less than 60% by 2013, despite the fact the general participation rates have continued increasing since 2006. In 2013, the participation rate of regional policyholders who were householders was 51%, while that of household members aged 40 or older was 59%. The rate among workplace policyholders’ dependents aged 40 or older was 66% in 2013; as can be seen, these figures are higher than are those of regional policyholders but lower than are those of workplace policyholders.
Regarding enterprise size among workplace policyholders, workers in enterprises with 50 to 299 employees showed the highest participation rates (77% and 84% in 2006 and 2013, respectively), and the rates gradually increased between 2006 and 2013. The second highest participation rates were shown among workplaces with 300 or more employees (74% and 82% in 2006 and 2013, respectively), and these rates gradually increased as well. Workplace policyholders at enterprises with less than 50 employees showed the lowest participation rates, at 67% and 70% in 2006 and 2013, respectively. The rates differed significantly from those of workers at enterprises with 50 or more employees.
Distribution of secondary examination participation rates
Table 2 shows the distribution of second examination participation rates. Data were available for about 0.99 million to 1.7 million individuals (see Table 2). In general, the participation rates were lower than were those of the primary health examination. Furthermore, despite the growth of primary examination participation rates over time, we observed no significance change or noticeable trend in secondary examination participation rates over the study period: in 2006, the rate was 35%, which then decreased to 30% in 2009 and increased again to 36% in 2013.
Table 2
Participation rates in secondary health examination
2006 2007 2008 2009
TSa (N) Pb (n, %) TS (N) P (n, %) TS (N) P (n, %) TS (N) P (n, %)
Overall participation rate 1,528,258 542,159 (35%) 1,510,570 494,307 (33%) 1,685,419 613,629 (36%) 1,338,668 531,368 (40%)
National health insurance type
Workplace policyholder
 Non-public worker 653,174 322,341 (49%) 665,972 302,288 (45%) 762,107 349,892 (46%) 770,863 353,721 (46%)
 Public official 101,161 30,023 (30%) 32,539 8,961 (28%) 88,985 28,977 (33%) 24,140 7,742 (32%)
 Dependents 391,370 97,262 (25%) 442,657 97,755 (22%) 454,519 124,020 (27%) 183,432 58,923 (32%)
Regional policyholder
 Householder 243,231 59,889 (25%) 238,327 56,214 (24%) 246,343 73,685 (30%) 236,901 74,466 (31%)
 Household member 139,322 32,644 (23%) 131,075 29,089 (22%) 133,465 37,055 (28%) 123,332 36,516 (30%)
Enterprise size (no. of employees)
  ≥ 300 275,350 136,199 (49%) 225,949 112,065 (50%) 268,608 129,066 (48%) 219,811 113,998 (52%)
 50–299 219,415 115,623 (53%) 197,555 101,858 (52%) 235,050 121,476 (52%) 209,477 115,495 (55%)
  < 50 269,550 104,625 (39%) 289,385 102,813 (36%) 358,311 133,238 (37%) 377,482 137,729 (36%)
Sex
 Male 978,849 389,925 (40%) 946,445 352,068 (37%) 1,073,130 427,195 (40%) 1,018,462 419,269 (41%)
 Female 549,409 152,234 (28%) 564,125 142,239 (25%) 612,289 186,434 (30%) 320,206 112,099 (35%)
Age
 20s 53,692 29,402 (55%) 53,881 28,447 (53%) 59,137 31,297 (53%) 51,077 25,389 (50%)
 30s 182,018 87,805 (48%) 174,085 82,411 (47%) 200,580 94,595 (47%) 173,040 79,718 (46%)
 40s 349,126 140,327 (40%) 320,442 115,845 (36%) 399,238 148,974 (37%) 326,432 135,562 (42%)
 50s 399,951 144,490 (36%) 381,998 137,387 (36%) 488,436 189,839 (39%) 392,327 154,592 (39%)
 60s 343,325 97,380 (28%) 353,618 84,869 (24%) 355,684 102,449 (29%) 349,726 125,906 (36%)
 70s 173,630 38,075 (22%) 192,742 40,215 (21%) 157,251 41,561 (26%) 233,235 71,208 (31%)
 80s 25,238 4,363 (17%) 32,230 4,844 (15%) 23,541 4,619 (20%) 92,784 22,048 (24%)
 90s 1,026 149 (15%) 1,327 138 (10%) 1,295 172 (13%) 13,937 2,607 (19%)
2010 2011 2012 2013
TS (N) P (n, %) TS (N) P (n, %) TS (N) P (n, %) TS (N) P (n, %)
Overall participation rate 1,013,976 414,029 (41%) 997,658 372,073 (37%) 1,154,033 429,375 (37%) 1,078,029 390,170 (36%)
National health insurance type
Workplace policyholder
 Non-public worker 597,762 280,244 (47%) 607,131 265,565 (44%) 576,320 267,880 (46%) 571,016 249,827 (44%)
 Public official 46,354 14,505 (31%) 22,112 5,313 (24%) 44,789 12,177 (27%) 21,650 5,225 (24%)
 Dependents 114,741 38,049 (33%) 110,150 31,263 (28%) 256,002 73,162 (29%) 247,981 69,859 (28%)
Regional policyholder
 Householder 175,332 56,573 (32%) 177,090 48,673 (27%) 190,654 52,647 (28%) 164,155 45,594 (28%)
 Household member 79,787 24,658 (31%) 81,175 21,259 (26%) 86,268 23,509 (27%) 73,227 19,665 (27%)
Enterprise size (no. of employees)
  ≥ 300 206,469 103,135 (50%) 189,163 94,346 (50%) 210,284 104,726 (50%) 189,634 96,030 (51%)
 50–299 174,351 94,622 (54%) 163,767 87,370 (53%) 173,687 92,500 (53%) 159,209 81,765 (51%)
  < 50 270,055 99,992 (37%) 281,230 91,208 (32%) 239,642 84,064 (35%) 245,452 78,007 (32%)
Sex
 Male 797,375 336,353 (42%) 784,090 304,117 (39%) 789,236 317,283 (40%) 733,806 286,863 (39%)
 Female 216,601 77,676 (36%) 213,568 67,956 (32%) 364,797 112,092 (31%) 344,223 103,307 (30%)
Age
 20s 42,001 21,505 (51%) 41,116 19,830 (48%) 36,470 17,710 (49%) 30,385 13,873 (46%)
 30s 160,820 74,726 (46%) 162,101 70,814 (44%) 155,709 71,811 (46%) 137,908 61,367 (44%)
 40s 303,173 122,650 (40%) 306,178 112,285 (37%) 303,601 116,296 (38%) 288,295 104,637 (36%)
 50s 332,857 133,182 (40%) 331,139 120,083 (36%) 341,649 129,235 (38%) 316,123 117,016 (37%)
 60s 208,220 77,363 (37%) 190,034 61,912 (33%) 190,899 65,006 (34%) 184,237 63,703 (35%)
 70s 102,762 28,613 (28%) 99,100 24,670 (25%) 104,077 26,562 (26%) 98,095 26,123 (27%)
 80s 17,925 3,388 (19%) 18,035 2,988 (17%) 19,829 2,424 (12%) 20,917 3,141 (15%)
 90s 1,093 141 (13%) 1,261 157 (12%) 1,362 90 (7%) 1,762 183 (10%)
aTS: Total subjects
bP: Participants in health examination
Regarding the differences by sex, the participation rates of male and female examinees was 40% and 28% in 2006, respectively; the highest participation rates were 42% and 36% in 2010, although they decreased to 39% and 30%, respectively, in 2013. As for age groups, the participation rates of examinees in their 20s were consistently the highest between 2006 and 2013, with the rates decreasing as age increased.
Regarding the insurance types, the participation rates of workplace policyholders were consistently the highest, as with the primary examination. However, the participation rates were lower than 50% in 2006 and 2013, at 49 and 44%, respectively. The participation rates of public officials, regional policyholders, and dependents were as low as 22–33%, and no significant difference was observed during the observation period.
For the enterprise size comparison, the secondary examination participation rates showed no significant differences by enterprise size and a non-significant increase by year. However, the workers at enterprises with less than 50 employees, which were generally lower than the participation rates of those with 50 or more employees, showed decreases in participation over time. Specifically, the participation rates at enterprises with less than 50 employees were 39% in 2006 and 32% in 2013. During the same periods, participation rates at enterprises with 50 to 299 employees were 53 and 51%, while those at enterprises with 300 or more employees were 49 and 51%, respectively. Thus, the gap in secondary examination participation rates between enterprises with less than 50 and those with 50 or more employees was considerable, as with the primary examination participation rates.
Prevalence rates of abnormal results among health screening examinees of the national health insurance service
Table 3 shows the distribution of examinees with abnormal results indicating diabetes and hypertension. Overall, the prevalence rates of diabetes and hypertension of the total were around 3 and 7% in 2006, respectively, and 6 and 17% in 2013.
Table 3
Prevalence rates of diabetes and hypertension among study population
2005 2006
DM HTN Diabetes Hypertension
Total subjects(N) Cases (N,%) Cases (N,%) Total (N) Cases (n, %) Cases (n, %)
Total prevalence
6,399,291 190,937 (3%) 462,760 (7%) 8,408,218 261,216 3.11% (3%) 668,277 7.9% (8%)
Nation health insurance type
 Regional policyholder + dependents 2,305,435 134,744 (6%) 349,530 (15%) 2,880,225 179,950 6.25% (6%) 484,164 16.8% (17%)
 Non-public worker
  Office worker 687,522 8,630 (1%) 15,481 (2%) 1,078,249 15,453 1.43% (1%) 32,584 3.0% (3%)
  Non-office worker 3,251,609 44,261 (1%) 91,635 (3%) 3,677,914 51,862 1.41% (1%) 118,429 3.2% (3%)
 Public official 154,725 3,302 (2%) 6,114 (4%) 771,830 13,951 1.81% (2%) 33,100 4.3% (4%)
Enterprise size
  ≥ 300 2,044,945 48,381 (2%) 114,524 (6%) 2,825,502 69,946 2.48% (2%) 176,557 6.25% (6%)
 50–299 1,387,051 33,339 (2%) 78,854 (6%) 1,905,700 46,342 2.43% (2%) 117,696 6.18% (6%)
  < 50 1,749,381 45,211 (3%) 110,543 (6%) 2,179,986 59,908 2.75% (3%) 154,446 7.08% (7%)
 Missing 1,217,914 64,006 158,839 1,497,030 85,020 5.68% 219,578 14.67%
Sex
 Male 3,767,406 108,226 (3%) 216,368 (6%) 4,858,065 147,842 3.04% (3%) 318,606 6.56% (7%)
 Female 2,631,885 82,711 (3%) 246,392 (9%) 3,550,153 113,374 3.19% (3%) 349,671 9.85% (10%)
Age
 20s 927,532 1,864 (0%) 1,671 (0%) 1,188,441 2,179 0.18% (0%) 2,185 0.18% (0%)
 30s 1,450,646 8,309 (1%) 11,403 (1%) 1,874,052 9,663 0.52% (1%) 15,952 0.85% (1%)
 40s 1,682,743 30,054 (2%) 60,911 (4%) 2,252,394 39,624 1.76% (2%) 90,148 4.00% (4%)
 50s 1,187,314 52,803 (4%) 128,562 (11%) 1,608,651 73,793 4.59% (5%) 189,496 11.78% (12%)
 60s 778,422 64,175 (8%) 159,391 (20%) 984,003 86,939 8.84% (9%) 222,100 22.57% (23%)
 70s 313,968 30,304 (10%) 87,743 (28%) 426,452 44,233 10.37% (10%) 129,941 30.47% (30%)
 80s 44,933 3,344 (7%) 12,732 (28%) 56,875 4,682 8.23% (8%) 17,922 31.51% (32%)
 90s 1,587 63 (4%) 339 (21%) 2,142 76 3.55% (4%) 525 24.51% (25%)
 Missing 12,146 12,146 12,146 15,208 27 8
2007 2008
Diabetes Hypertension Diabetes Hypertension
Total (N) Cases (n,%) Cases (n,%) Total (N) Cases (n,%) Cases (n,%)
Total prevalence
8,419,532 265,813 3.16% (3%) 708,647 8.42% (8%) 10,264,420 331,893 3.23% (3%) 900,056 8.77% (9%)
Nation health insurance type
 Regional policyholder + dependents 3,189,796 190,808 5.98% (6%) 528,428 16.57% (17%) 3,531,109 221,581 6.28% (6%) 619,038 17.53% (18%)
 Non-public worker
  Office worker 839,517 10,055 1.20% (1%) 21,177 2.52% (3%) 2,044,152 32,126 1.57% (2%) 77,571 3.79% (4%)
  Non-office worker 4,176,693 60,694 1.45% (1%) 149,595 3.58% (4%) 3,909,321 63,217 1.62% (2%) 164,400 4.21% (4%)
 Public official 213,526 4,256 1.99% (2%) 9,447 4.42% (4%) 779,838 14,969 1.92% (2%) 39,047 5.01% (5%)
Enterprise size
  ≥ 300 2,663,471 68,577 2.57% (3%) 183,148 6.88% (7%) 3,195,498 86,921 2.72% (3%) 235,100 7.36% (7%)
 50–299 1,768,735 46,586 2.63% (3%) 121,795 6.89% (7%) 2,235,709 59,410 2.66% (3%) 161,778 7.24% (7%)
  < 50 2,443,371 67,316 2.76% (3%) 182,838 7.48% (7%) 3,133,715 90,022 2.87% (3%) 247,560 7.90% (8%)
 missing 1,543,955 83,334 5.40% 220,866 14.31% 1,699,498 95,540 5.62% 255,618 15.04%
Sex
 Male 4,833,287 146,782 3.04% (3%) 328,619 6.80% (7%) 5,763,063 188,671 3.27% (3%) 435,431 7.56% (8%)
 Female 3,586,245 119,031 3.32% (3%) 380,028 10.60% (11%) 4,501,357 143,222 3.18% (3%) 464,625 10.32% (10%)
Age
 20s 1,199,391 1,919 0.16% (0%) 2,264 0.19% (0%) 1,413,162 2,086 0.15% (0%) 2,905 0.21% (0%)
 30s 1,764,649 9,132 0.52% (1%) 16,115 0.91% (1%) 2,170,990 10,824 0.50% (0%) 21,503 0.99% (1%)
 40s 2,156,367 35,167 1.63% (2%) 84,647 3.93% (4%) 2,677,379 45,085 1.68% (2%) 113,828 4.25% (4%)
 50s 1,620,394 75,899 4.68% (5%) 200,596 12.38% (12%) 2,067,020 101,633 4.92% (5%) 273,742 13.24% (13%)
 60s 1,081,039 81,470 7.54% (8%) 214,586 19.85% (20%) 1,260,900 93,829 7.44% (7%) 251,245 19.93% (20%)
 70s 504,698 55,267 10.95% (11%) 163,285 32.35% (32%) 575,863 70,028 12.16% (12%) 204,293 35.48% (35%)
 80s 77,305 6,805 8.80% (9%) 26,294 34.01% (34%) 82,816 8,214 9.92% (10%) 31,491 38.03% (38%)
 90s 3,063 140 4.57% (5%) 850 27.75% (28%) 3,276 175 5.34% (5%) 1,043 31.84% (32%)
 Missing 12,626 14 10 13,014 19 6
2009 2010
Diabetes Hypertension Diabetes Hypertension
Total (n) Cases (n, %) Cases (n, %) Total (n) Cases (n, %) Cases (n, %)
Total prevalence
10,537,866 535,904 5.09% (5%) 1,481,623 14.06% (14%) 11,491,730 612,976 5.33% (5%) 1,762,190 15.33% (15%)
Nation health insurance type
 Regional policyholder + dependents 4,051,519 345,125 8.52% (9%) 971,687 23.98% (24%) 4,470,443 411,405 9.20% (9%) 1,164,126 26.04% (26%)
 Non-public worker
  Office worker 2,049,755 56,098 2.74% (3%) 155,502 7.59% (8%) 2,088,031 63,998 3.06% (3%) 177,668 8.51% (9%)
  Non-office worker 4,240,682 129,358 3.05% (3%) 340,193 8.02% (8%) 4,326,907 122,166 2.82% (3%) 373,474 8.63% (9%)
 Public official 195,910 5,323 2.72% (3%) 14,241 7.27% (7%) 606,349 15,407 2.54% (3%) 46,922 7.74% (8%)
Enterprise size
  ≥ 300 3,119,928 153,087 4.91% (5%) 397,562 12.74% (13%) 3,546,046 162,448 4.58% (5%) 466,600 13.16% (13%)
 50–299 2,125,705 88,321 4.15% (4%) 259,239 12.20% (12%) 2,371,029 104,584 4.41% (4%) 314,656 13.27% (13%)
  < 50 3,456,632 157,402 4.55% (5%) 454,658 13.15% (13%) 3,422,505 172,856 5.05% (5%) 509,232 14.88% (15%)
 Missing 1,835,601 137,094 7.47% 370,164 20.17% 2,152,150 173,088 8.04% 471,702 21.92%
Sex
 Male 5,816,276 308,519 5.30% (5%) 742,507 12.77% (13%) 6,323,006 352,891 5.58% (6%) 907,367 14.35% (14%)
 Female 4,721,590 227,385 4.82% (5%) 739,116 15.65% (16%) 5,168,724 260,085 5.03% (5%) 854,823 16.54% (17%)
Age
 20s 1,305,813 3,015 0.23% (0%) 10,025 0.77% (1%) 1,232,879 2,055 0.17% (0%) 8,477 0.69% (1%)
 30s 2,014,012 18,180 0.90% (1%) 46,242 2.30% (2%) 2,240,262 16,926 0.76% (1%) 48,791 2.18% (2%)
 40s 2,744,518 82,776 3.02% (3%) 198,893 7.25% (7%) 3,017,490 81,254 2.69% (3%) 220,462 7.31% (7%)
 50s 2,235,227 146,546 6.56% (7%) 407,900 18.25% (18%) 2,598,385 176,686 6.80% (7%) 513,783 19.77% (20%)
 60s 1,421,468 170,971 12.03% (12%) 471,277 33.15% (33%) 1,513,228 197,633 13.06% (13%) 553,203 36.56% (37%)
 70s 692,595 101,393 14.64% (15%) 297,958 43.02% (43%) 746,457 121,671 16.30% (16%) 354,564 47.50% (47%)
 80s 104,206 12,659 12.15% (12%) 47,414 45.50% (46%) 118,893 16,238 13.66% (14%) 60,176 50.61% (51%)
 90s 4,676 338 7.23% (7%) 1,843 39.41% (39%) 6,122 479 7.82% (8%) 2,648 43.25% (43%)
 Missing 15,351 26 71 18,014 34 86
2011 2012 2013
Diabetes Hypertension Diabetes Hypertension Diabetes Hypertension
Total (N) Cases (n, %) Cases (n, %) Total (N) Cases (n, %) Cases (n, %) Total (N) Cases (n, %) Cases (n, %)
Total prevalence
11,739,774 660,173 5.62% (6%) 1,894,835 16.14% (16%) 12,083,276 720,785 5.97% (6%) 2,036,249 16.85% (17%) 12,108,885 752,479 6.21% (6%) 2,092,682 17.28% (17%)
Nation health insurance type
 Regional policyholder + dependents 4,743,687 453,771 9.57% (10%) 1,268,580 26.74% (27%) 4,935,574 500,276 10.14% (10%) 1,366,098 27.68% (28%) 4,875,356 516,196 10.59% (11%) 1,392,427 28.56% (29%)
 Non-public worker
  Office worker 2,302,668 67,656 2.94% (3%) 191,364 8.31% (8%) 2,120,013 67,636 3.19% (3%) 192,517 9.08% (9%) 2,091,641 66,376 3.17% (3%) 182,837 8.74% (9%)
  Non-office worker 4,442,913 130,895 2.95% (3%) 413,879 9.32% (9%) 4,458,500 135,218 3.03% (3%) 425,481 9.54% (10%) 4,860,568 160,762 3.31% (3%) 492,731 10.14% (10%)
 Public official 250,506 7,851 3.13% (3%) 21,012 8.39% (8%) 569,189 17,655 3.10% (3%) 52,153 9.16% (9%) 281,320 9,145 3.25% (3%) 24,687 8.78% (9%)
Enterprise size
  ≥ 300 3,482,842 163,177 4.69% (5%) 486,099 13.96% (14%) 3,786,158 185,987 4.91% (5%) 543,384 14.35% (14%) 3,748,268 190,627 5.09% (5%) 548,147 14.62% (15%)
 50–299 2,268,129 110,318 4.86% (5%) 326,985 14.42% (14%) 2,455,925 123,225 5.02% (5%) 360,713 14.69% (15%) 2,400,555 128,615 5.36% (5%) 367,928 15.33% (15%)
  < 50 3,689,450 193,974 5.26% (5%) 564,875 15.31% (15%) 3,350,385 189,917 5.67% (6%) 553,200 16.51% (17%) 3,625,079 215,483 5.94% (6%) 610,829 16.85% (17%)
 Missing 2,299,353 192,704 8.38% 516,876 22.48% 2,490,808 221,656 8.90% 578,952 23.24% 2,334,983 217,754 9.33% 565,778 24.23%
Sex
 Male 6,443,675 375,531 5.83% (6%) 972,053 15.09% (15%) 6,603,480 414,207 6.27% (6%) 1,064,970 16.13% (16%) 6,613,771 430,830 6.51% (7%) 1,092,632 16.52% (17%)
 Female 5,296,099 284,642 5.37% (5%) 922,782 17.42% (17%) 5,479,796 306,578 5.59% (6%) 971,279 17.72% (18%) 5,495,114 321,649 5.85% (6%) 1,000,050 18.20% (18%)
Age
 20s 1,245,499 2,072 0.17% (0%) 8,713 0.70% (1%) 1,147,620 1,908 0.17% (0%) 7,648 0.67% (1%) 1,062,788 1,837 0.17% (0%) 6,964 0.66% (1%)
 30s 2,213,257 15,526 0.70% (1%) 51,580 2.33% (2%) 2,250,399 15,710 0.70% (1%) 50,231 2.23% (2%) 2,143,148 13,730 0.64% (1%) 45,107 2.10% (2%)
 40s 3,071,894 82,047 2.67% (3%) 229,048 7.46% (7%) 3,110,001 85,978 2.76% (3%) 238,180 7.66% (8%) 3,206,437 87,144 2.72% (3%) 235,812 7.35% (7%)
 50s 2,710,203 190,651 7.03% (7%) 550,829 20.32% (20%) 2,895,631 206,781 7.14% (7%) 591,902 20.44% (20%) 2,896,439 208,241 7.19% (7%) 587,063 20.27% (20%)
 60s 1,517,664 207,082 13.64% (14%) 572,466 37.72% (38%) 1,610,092 223,860 13.90% (14%) 610,749 37.93% (38%) 1,681,885 238,413 14.18% (14%) 638,455 37.96% (38%)
 70s 815,426 141,384 17.34% (17%) 405,298 49.70% (50%) 885,701 161,244 18.21% (18%) 449,970 50.80% (51%) 917,989 172,334 18.77% (19%) 475,139 51.76% (52%)
 80s 136,226 20,679 15.18% (15%) 73,267 53.78% (54%) 149,655 24,369 16.28% (16%) 83,411 55.74% (56%) 172,632 29,530 17.11% (17%) 98,320 56.95% (57%)
 90s 7,667 687 8.96% (9%) 3,523 45.95% (46%) 8,336 874 10.48% (10%) 4,047 48.55% (49%) 11,183 1,220 10.91% (11%) 5,749 51.41% (51%)
 Missing 21,938 45 111 25,841 61 111 16,384 30 73
Regarding the differences by sex, we observed no significant differences in the prevalence rate of diabetes, although male examinees had a slightly higher rate. In contrast, the rate of hypertension was higher among female examinees than among male examinees. Notably, the rates increased in proportion with age.
As for insurance types, the ratio of regional policyholders was higher than that of workplace policyholders. However, it must be taken into account that the ratios of working ages (i.e., those under the retirement age) were relatively higher among workplace policyholders, while the ratio of elderly persons aged 60 or older was higher among regional policyholders (not presented in the table), which could have affected the prevalence rate results (given that older adults are more likely to have blood pressure and blood glucose abnormalities). Table 3 also shows the ratios of examinees with abnormal results among workplace policyholders who were office workers, non-office workers, and public officials, as well as the ratios depending on enterprise size. Except for the ratios of diabetes in 2009, workers at enterprises with less than 50 employees showed higher ratios of abnormal results of diabetes and hypertension than did workers at workplaces with 50 or more employees.
Odds ratios of abnormal results among workplace policyholders depending on enterprise size
Table 4 shows the odds ratios of abnormal results of diabetes and hypertension among workers in their 40s and 50s by enterprise size, with enterprises of 300 or more employees as the reference. The overall odds ratios of diabetes among those in their 40s and 50s, along with odds ratios of diabetes among those in their 40s in 2009 and 2010, were all less than 1. Among the remaining examinees, the odds ratios of diabetes and hypertension among workers at enterprises with less than 300 employees tended to be higher than did those among workers at enterprises with 300 or more employees. More specifically, workers at enterprises with less than 50 employees showed the highest odds ratios for both diabetes and hypertension compared to workers at enterprises with 50 or more employees.
Table 4
Odds ratios of diabetes and hypertension among workplace policyholders in their 40s and 50s by enterprise size (2006–2013)
Diabetes Hypertension
40s 50s 40s 50s
Year Enterprise size (no. of employees) OR 95% CI OR 95% CI OR 95% CI OR 95% CI
2006
  ≥ 300 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
 50 ~ 299 1.071 (1.04 – 1.102) 1.022 (0.999 – 1.045) 1.093 (1.071 – 1.114) 1.041 (1.026 – 1.057)
  < 50 1.204 (1.171 – 1.238) 1.07 (1.046 – 1.093) 1.259 (1.236 – 1.283) 1.108 (1.092 – 1.124)
2007
  ≥ 300 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
 50 ~ 299 1.169 (1.132 – 1.207) 1.107 (1.082 – 1.133) 1.163 (1.138 – 1.188) 1.062 (1.046 – 1.078)
  < 50 1.253 (1.216 – 1.29) 1.129 (1.105 – 1.153) 1.346 (1.321 – 1.373) 1.155 (1.14 – 1.171)
2008
  ≥ 300 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
 50 ~ 299 1.041 (1.012 – 1.071) 1.036 (1.016 – 1.057) 1.107 (1.088 – 1.127) 1.036 (1.024 – 1.049)
  < 50 1.168 (1.138 – 1.199) 1.074 (1.055 – 1.094) 1.264 (1.243 – 1.285) 1.116 (1.103 – 1.129)
2009
  ≥ 300 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
 50 ~ 299 0.555 (0.543 – 0.567) 0.955 (0.939 – 0.971) 0.837 (0.826 – 0.849) 1.011 (1.001 – 1.022)
  < 50 0.615 (0.604 – 0.627) 0.976 (0.962 – 0.991) 0.898 (0.887 – 0.909) 1.052 (1.042 – 1.062)
2010
  ≥ 300 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
 50 ~ 299 0.907 (0.888 – 0.926) 1.028 (1.013 – 1.044) 1.071 (1.057 – 1.085) 1.037 (1.027 – 1.047)
  < 50 0.97 (0.952 – 0.988) 1.058 (1.044 – 1.072) 1.131 (1.118 – 1.144) 1.068 (1.059 – 1.077)
2011
  ≥ 300 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
 50 ~ 299 1.124 (1.121 – 1.128) 1.097 (1.095 – 1.099) 1.085 (1.071 – 1.099) 1.065 (1.055 – 1.075)
  < 50 2.535 (2.483 – 2.588) 1.996 (1.971 – 2.022) 1.114 (1.102 – 1.127) 1.078 (1.069 – 1.088)
2012
  ≥ 300 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
 50 ~ 299 1.052 (1.031 – 1.074) 1.063 (1.048 – 1.078) 1.071 (1.058 – 1.084) 1.062 (1.052 – 1.071)
  < 50 1.098 (1.078 – 1.119) 1.048 (1.035 – 1.061) 1.113 (1.101 – 1.126) 1.069 (1.06 – 1.077)
2013
  ≥ 300 1.0 (ref) 1.0 (ref) 1.0 (ref) 1.0 (ref)
 50 ~ 299 1.047 (1.026 – 1.069) 1.109 (1.093 – 1.125) 1.063 (1.05 – 1.076) 1.087 (1.077 – 1.096)
  < 50 1.082 (1.063 – 1.102) 1.082 (1.068 – 1.096) 1.087 (1.075 – 1.1) 1.092 (1.083 – 1.101)
In the following section, we explore the history of the Korean health screening system and the present national health screening and workers’ health examinations. We believe that, to understand the modern Korean health screening system, it is necessary to look back on the history of health screening. This will provide some information on how the current policies, institutions, and attitudes and culture of the people concerning this topic have been formed.
History of health examination and domestic system of national general health screening
Although the specific origin of organized health examinations (OHEs) is uncertain, the first recorded regular health examination/screening dates back to the 14th century [8]. In modern medical science, the concept of performing a health screening for those without particular symptoms was first suggested by Horace Dobell, a medical scientist in the UK [9]. In the US, the first health screenings were conducted in the mid-19th century among immigrants in line with quarantine inspections [10]. In the 20th century, Gould suggested the necessity of OHEs for general population groups, becoming the first promoter of general health examinations in the formal academic literature [11, 12]. Until the early 20th century, health examinations were conducted in the western world mainly in order to control outbreaks of infectious diseases such as tuberculosis [13].
As the number of patients with tuberculosis decreased in the late 1950s, more doctors began proposing that the scope of disease prevention through health examination should be broadened to cover chronic diseases [14, 15]. Thereafter, changes in the roles of medical doctor groups [16] and life insurance companies, the emergence of preventive medicine, the lingering effects of the World Wars, etc., [17] resulted in an expansion of health examinations throughout various areas of society. In the 1960s, several critical and scientific studies revealed that many elements of the health examinations conducted at those times were not scientifically verified in terms of their predictive ability of treatment outcomes [1820]. This led to a number of the more detailed questions and physical examinations, which had once been key elements of regular health examinations, no longer being recommended. Thereafter, general medical preventive examinations conducted as part of the national insurance system for the general population became relatively rare in western countries [10].
Given this background, it can be said that the Korean NGHE is a rather unique medical service around the world. The concept of health examination for groups without specific symptoms was first introduced in the Republic of Korea around the time of the national liberation in 1945. After the liberation in 1945, health examinations began being institutionalized, starting with the examination of parasites and infectious diseases such as tuberculosis [21]. The national health examination system was initiated as part of the national medical insurance in 1977; before this, health examinations were conducted individually according to specific needs and subjects.
From 1977, all companies with more than 500 employees were required to provide health insurance services. The health insurance coverage expanded to cover companies with 300 or more employees, public workers, and school personnel in 1979, and thereafter its coverage expanded to even smaller companies. Finally, the self-employed were included under national health insurance coverage in 1989 as regional policyholders. Since 1995, national medical insurance covered both public health services and national health screening. However, between 1977 and 1995, the Ministry of Labor took charge of both the WGHE and WSHE; during this period, the national health screening service could not be used as a substitute for the WGHE. In 1995, authority of the health examination service was transferred to the Ministry of Health and Welfare as part of the National Health Promotion Act; thereafter, health insurance policyholders were able to claim health examination services under their insurance coverage [21]. The employers’ obligation of reporting the results of the WGHE to local branch of the Ministry of Labor ceased in 1997, while the obligation of reporting to the Korea Occupational Safety and Health Agency (KOSHA) was ceased in 2005 [22]. All health insurance societies were integrated into a single insurer, the National Health Insurance Program, in 2000 [23]. The health examination system has been continually expanded with successive acts since, including the Framework Act on Health Examination in 2008, the 1st 5-year plan for the NGHE in 2010, etc., and with the establishment of the 2nd 5-year plan for the NGHE in 2016. This act has led to the current examination system and framework of operation [1, 24].
Beginning of current WGHE and participation rates of workplace policyholders
The NGHE, which is provided to workplace policyholders (i.e., beneficiaries of national health insurance), is a replacement of the WGHE originally specified as a duty of business owners for employee health protection designated by the Industrial Safety and Health Act. One major historical change in the domestic health examination system for workers [25] was the Labor Standard Act’s stipulation in 1953 that enterprises with 16 or more employees must provide regular health examinations for workers. The major subjects of this legislation were miners. In 1961, regulations on workers’ health management were announced, specifying the types, subjects, contents, and intervals of the health examinations. Then, in 1972, health examinations were divided into the WSHE and WGHE, depending on the hazardous substances that workers would be exposed to in their workplaces. The enforcement ordinances of the Industrial Safety and Health Act were subsequently revised in 1981, which stipulated that business owners of business entities with 5 or more employees were obligated to provide workers with health examination services. This also led office workers to being distinguished from non-office workers, and the interval of the WGHE for office workers being extended from 1 year to 2 [26]. In 1995, when the national health examination service was transferred to the Ministry of Health and Welfare, the coverage of national health examination services was expanded to include the general population in accordance with the National Health Insurance Service Act. As the national NGHE was acknowledged as a type of general health examination service, the expenses for the WGHE, which had previously been borne by business owners, were taken up by the National Health Insurance Service. The enforcement regulations of the Industrial Safety and Health Act were again revised in 1997, thus leading to the abolishment of business owners’ obligation to report general health examination results. In 2002, every workplace with 1 or more workers was required to offer health examination services, while 2005 saw the discontinuation of health examinations specifically targeting new employees. Since then, the NGHE for workplace policyholders has replaced the WGHE according to the Industrial Safety and Health Act [24].
The increase in the WGHE participation rate and health effect
We found that participation rates have rapidly increased over the last decade, from 51.6% in 2005 to 56% in 2006 and over 70% in 2011; since then, the rates have continued at a steady rate of around 70%. It is possible that these findings are the results of increasing income, the low-cost medical services of the NGHE, and a chronic disease prevention project. Another possibility is that the Industrial Safety and Health Act's mandating business owners to provide general health examinations for workplace policyholders has helped maintain the relatively high participation rates among such policyholders. Indeed, the participation rate of workplace policyholders was already 77% in 2006, which was substantially higher than the participation rate of the total population of the NHIS beneficiaries. Since 2007, the rates have been continually high, reaching upwards 80%. Another reason for the high participation could be the fact that examination agencies dispatch examiners to each workplace to provide these services, making them easily accessible by workers. However, it should be noted that a number of problems with the onsite health examination service have been pointed out, and its discontinuation has been discussed [1]. Thus, the effectiveness of this service should be discussed further in the future.
Regarding the comparison of participation rates among different enterprise sizes, we noted that the participation rates were lower among workers employed at enterprises with fewer than 50 employees than among those with 50 or more employees, and this gap remained consistent over the study period from 2006 to 2013. A possible reason for this is that National Health Insurance Program began by targeting workers of relatively large enterprises, who are more likely to be able afford to pay health insurance taxes; it has only rather recently expanded to workers from smaller enterprises and the self-employed, who generally have more unstable incomes. However, the consistent gap in health examination participation may mean that there remains a disparity in health examination opportunity due to socioeconomic status. In summary, participation rates are high overall, but there remain problems of unequal opportunities of health examination [27].
As for the age groups, the participation rates among the older generations—those in their 40s and 50s—were relatively low from 2006 to 2013 compared to examinees in their 20s and 30s, although the rates of each age group have been increasing. It should be noted, however, that these are merely the participation rates of NGHE beneficiaries. The dependents and household members of individuals in their 20s and 30s who were not workplace or regional policyholders would not be included among such beneficiaries. According to the Law for Health Promotion in the Republic of Korea [7, 28], only dependents or household members of an employee subscriber (i.e., workplace policyholder) or district subscriber (i.e., regional policyholder) who are 40 years old and above can receive the NGHE every other year. Thus, the participation rates of individuals in their 40s and above may reflect the total rate of all of these individuals in the NGHE because they are all given the opportunity to take it for free. In contrast, the dependents of national health subscribers below 40 years old would be excluded from the opportunity to take the NGHE. Thus, our results do not indicate that certain age groups show higher participation rates, but rather illustrate the number of beneficiaries in each age group who actually took the health examination.
Follow-up management of health examination and secondary examination participation rates
In general, there is no common formal definition of concepts such as OHEs, periodic health exams, and screenings. Nevertheless, they all refer to health screening services utilizing tests to identify possible disease [13]. Additionally, the basic purpose of such examinations is to prevent targeted diseases and promote health. To this end, routine screenings and immunizations are strategically performed [29].
Article 52 of the National Health Insurance Service states that the “The Corporation shall conduct health examinations to find diseases among policyholders and their dependents as early as possible and to provide medical care benefits.”[28] Furthermore, Article 43 of the Industrial Safety and Health Act and Article 98 of the enforcement regulation of that same act state that “health examination shall be conducted regularly for workers’ health management”[30]. In other words, it may be considered that the concept of health examination includes efforts for improving the health conditions of examinees with abnormal results in addition to providing diagnoses.
Despite the increasing participation rates for the primary health examination, we observed no concomitant increase in the secondary health examination for examinees with abnormal results to ensure early detection and treatment. As was suggested in the secondary health examination results, we assume that this is due to the lack of follow up management in the NGHE system. Follow-up management refers to “additional intervention for those who are found to need further measures as a result of screening such as confirmation of a diagnosis, education, and consultation” [1]. In other words, the combination of a health examination with follow-up management would include all the procedures necessary to designate which examinees with abnormal results should visit medical centers for treatment or management services. Problems in this regard have been pointed out in the past as well [22, 31]. Furthermore, the ratio of examinees with abnormal results of diabetes and hypertension who visited outpatient department hospitals to diagnose their abnormal results and receive a prescription was low. This accords with a previous study among examinees who received medical treatment—specifically, those who had visited a medical center for their hypertension or diabetes with 90 days of examination accounted for only 2.21% and 1.18%, respectively [32].
Notably, the secondary examination participation rates were substantially higher among workplace policyholders than among other subjects; however, their participation rates did not show any increases over the study period. In particular, in comparing secondary examination participation rates among the different enterprise sizes, we found that participation rates in small enterprises (those with less than 50 employees) decreased somewhat over time, and were far below the rates of workers in enterprises with 50 or more employees. This gap in participation rates was even greater for the secondary examination than for the primary. Previous studies have shown that, among examinees who were suspected of having diabetes or showed abnormal results on the fasting glucose level test, only 5.66% sought out further medical examination for diabetes within 90 days [33]. In addition to follow-up management, there should be further research on the contribution of health examinations—both secondary and primary—to early diagnosis and treatment.
It may be helpful for specialized agencies for workplace health management and their affiliated health care professionals to fulfill the health management tasks of small-to-medium size enterprises through utilization of the current system. According to one survey conducted among medical practitioners of specialized agencies for workplace health management, workers showed a high level of compliance with advice for further medical treatment when diagnosed with abnormal results as a result of a health examination [34]. Thus, making good use of the existing system will be a way of maximizing the preventive effects of health examinations.
Prevalence of diabetes and hypertension
Our results indicated that the prevalence rates of diabetes and hypertension have increased since 2006. This coincides with the increase in participation rates during that same period. Similarly, the prevalence rates leveled off at the same point—around 2011—as did the participation rates. However, these findings merely indicate the similarities in the graphs of participation rates and prevalence rates of diabetes and hypertension; they do not prove that higher participation rates indicate a higher probability of detecting more patients with diabetes and hypertension. In order to control for various factors possibly influencing this similarity, such as aging of the screening population, in the future, it would be necessary to observe the situation over the long term (Fig. 1).
Fig. 1
Changes in participation rates and the prevalence of diabetes and hypertension. Note: DM, diabetes; HTN, hypertension
40557_2017_157_Fig1_HTML.jpg
As noted above, high blood glucose and blood pressure can be risk factors of CCVDs. Diseases of the circulatory system are the second most common cause of morbidity and mortality next to cancer in the Republic of Korea. Furthermore, CCVDs are compensable occupational diseases in the Republic of Korea, as in Japan or Taiwan [35]. They are a major cause of death and workforce loss among workers as well as in the general population in the Republic of Korea. When we classified workplace policyholders by their enterprise size, we noted that the prevalence and odds of having abnormal results relating to diabetes and hypertension were relatively higher among workers at an enterprise with less than 50 employees, who also demonstrated low participation rates. This same trend was found among the different age groups as well. As was mentioned above, the national health care and worker health care policies in Republic of Korea have only recently expanded their coverage from large enterprises to small ones [21]. Thus, the disparity between workers of these two types of companies indicates a health disparity due to socioeconomic status. Socioeconomic disparities in the prevalence of CCVDs and their risk factors in the Republic of Korea [36] and other countries [37, 38] have also been described in other studies. However, Korean examination agencies are allowed to dispatch their examiners to each workplace to provide such services. It is possible that examinees' blood pressure in the onsite examination is not as stable as that measured in the hospital, and some examinees, particularly those who have just a finished night shift, may not have fasted before a health examination.
Health examination opportunity and health disparity
Small enterprise workers have less WGHE opportunity and have more abnormal results relating to diabetes and hypertension. A reason for the lower participation rates and higher rates of diabetes and hypertension among workers from smaller enterprises may be related to inequality in health and socioeconomic conditions. Specifically, the Ministry of Employment [39], the difference in monthly wages increases along with the scale of the business entity in South Korea: namely, the monthly wage at business entities with 300 or more employees was about 147% that of entities with 10–29 employees. When the difference in monthly wages between enterprise size was examined according to the Korean standard statistical classification of occupation (http://kssc.kostat.go.kr/ksscNew_web/ekssc/main/main.do), service workers (170%) and craft and related trades workers (165%) showed the largest gaps in monthly wages, while managers (116%) showed a relatively smaller gap. These differences in wages, along with other socioeconomic factors, may help to limit opportunities for health examination. Further support for this comes from a previous cohort study, wherein the occurrence of cardiovascular diseases was observed among examinees for 7 years [27]. The authors found that the occurrence rate was lower among individuals who regularly underwent health examinations. Furthermore, the subjects were broken down and examined by insurance type—non-office workers, who could take a health examination every year; office workers and regional policyholders, who would take a health examination every two years; and dependents of these policyholders for comparison. The results revealed that the gap in occurrence rate of cardiovascular disease between individuals who took health examinations regularly and those who did not was smallest among non-office workers (who could take a health examination every year). Thus, relatively healthy workers with better working conditions appear to be given more opportunities for health examination. Taken together, these previous studies indicate that the gap of health conditions narrows as the interval between health examinations shortens, suggesting that health examinations can serve as a social safety net so long as they are conducted regularly and further necessary treatment is provided through follow-up management.
Cho et al. pointed out that the differing participation rates by socioeconomic factors is one problem of the Korean national health examination system [40]; Myeong et al. also noted a participation disparity of workers in small workplaces (i.e., those with less than 50 employees): they estimated the odds ratios of participation in the WGHE by the size of enterprise, and found that workers employed at enterprises with less than 50 workers were less likely to participate in the WGHE than were those employed at enterprises with more than 300 workers [41]. Among public officials, whose working conditions are relatively stable, the difference in participation rates by enterprise size was non-significant. Overall, our results suggest that the poorer working conditions at small workplaces may limit opportunities for health examination.
This study examined the current condition of the WGHE and the NGHE using national data. We identified the annual changes in participation rates of the NGHE. We also analyzed the data in terms of occupational medicine. While the overall participation rate is increasing, we found that participation was lower among smaller enterprise employees.
Notably, this study has some limitations: First, among the many chronic diseases assessed in the examination, we examined only the prevalence and odds of diabetes and hypertension. However, the targeted diseases or subjects that can be assessed by the items of the current health examination are somewhat vague. It would be necessary for future research to target other diseases for specific organs, such as hematologic, liver, and nephrotic disease; urogenital disorders; and auditory disorder [31, 42], in order to grasp the current condition of workers’ health examination.
The WGHE can be regarded as a method of health surveillance for workers exposed to vocational dangers. Berlin et al. [43] defines health surveillance as “regular clinical and physiological examination conducted to protect health of workers exposed to hazardous substances and to prevent diseases.” To make the government and business entities adopt consistent policies regarding the promotion of vocational health and thereby improve working conditions, the International Labor Organization has presented Occupational Health Services Convention (C161) [6], which specifies 11 basic duties for the protection of workers’ physical and mental health and the necessary aspects of health surveillance to that end. It is noteworthy that the tests in the WGHE target specific organs rather than diseases, as this allows for the inclusion of the preventive effects of little-known diseases. In consideration of the fact that some production line workers may be exposed to potentially hazardous substances even if these substances are not specified by law, test items targeting uncertain diseases also can play a role in surveillance of potential dangers. Furthermore, prevention of cardiovascular diseases is one of the most important objectives of the WGHE and NGHE.
Second, the results regarding the prevalence and odds of diabetes and hypertension provide estimates of who may be in need of medical treatment, but cannot provide clear diagnoses. More specifically, the figures determined cannot be considered wholly accurate because of the following factors: not all health examinations were performed in a fasting state; the examination process was relatively quick and conducted by a large-scale workforce; poor examination conditions in the case of onsite health examination services; white coat syndrome among examinees, etc.
Third, the distinction between office workers and non-office workers might cause confusion. According to domestic health examination law, office work is limited to clerical workers separated from production sites and do not engage in interactive services. Since job concepts in modern society are highly diverse, the concept stated in this study may be different from the concepts among manual workers/non-manual workers or blue-/white-collar workers. Furthermore, many of those who are classified as non-office workers primarily work at an office, whereas individuals that can be classified as white-collar according to commonly accepted notions may be classified as non-office workers.
Finally, we did not adjust for population age. As the population age structure changes annually, not controlling for it precludes detailed comparison and application of the results to specific groups. Nevertheless, the national data include all national health insurance beneficiaries. We also compared the data annually so that the differences in the population structures of each year were not large enough to produce a severe confound.
Despite these limitations, our study is of significance in that it clarifies the differences between the primary and secondary examination participation rates and the differences in the occurrence of diabetes and hypertension by enterprise size. Our results regarding enterprise size suggest that many workers at small workplaces suffer from inequality of health conditions and opportunities for health examination; given that the majority of domestic workers are now working in enterprises with less than 50 employees [39], these results are particularly relevant today.
Our study also suggests the need to take note of realistic participation rates along with the medical effects when deciding on the appropriate interval between health examinations, as low participation rates can result in extension of the actual health examination interval. Furthermore, medical guidelines for health examination intervals may vary depending on the target population’s accessibility to health examinations. Notably, compared to past health examination services, participation in the current health examination service was relatively high. However, in terms of the prevention of diseases, one of the purposes of health examination, it will be helpful to consider long-term average participation rates rather than participation rates of a single health examination in determining an effective interval of examination. For health examination to contribute to the prevention of diseases, studies of both of the examination participation rates and follow-up management are necessary. Supplementary measures also need to be developed for groups found to be in poor condition.
Funding
This study was supported by the Korean Occupational Safety and Health Agency (2015-OSHRI-1147).
Availability of data and materials
The National General Health Examination data set is provided by the National Health Insurance Services (NHIS); it is fully encoded and has randomized identification numbers to make it impossible to identify individual participants or link the NGHE data to other data.
Authors’ contributions
EK, YK, JM, BH was planed the study and correct the data. EK, YK, BC, JP analyzed the data. YK, JM and EK descriped the results and discussion. EK, YK, JM, JM, JP. reviewed and revised the dicussion, introduction and result. EK, YK, JM completed conclusion. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Ethics approval and consent to participate
Our study was approved by the Institutional Review Board of the Occupational Safety and Health Research Institute of the Korean Occupational Safety and Health Agency (OSHRI-2016-06).

NGHE

National general health examination

NHIS

National health insurance service

OHE

Organized health examination.

WGHE

Workers’ general health examination

WSHE

Workers’ special health examination
  • 1. Korea Centers for Disease Control and Prevention. An establishment of comprehensive plans for national health examination. 2010.
  • 2. Yoon YD, Seo SR, Kim HC. An evaluation of the effect of national general health examination. 2010, Seoul: Health Insurance Policy Research Institute in the National Health insurance Service.
  • 3.
  • 4. Lee SI, Jo MW. Cost-effectiveness analysis of cervix cancer screening program in Korea. Korea J Health Promot Dis Prev 2003;3:18–26.
  • 5. Corporation NHI. Cost-effectiveness analysis of type 2 DM screening program of the national health insurance. 2006, Seoul: National Health Insurance Corporation.
  • 6. Stellman JM. Encyclopaedia of occupational health and safety. 1998, Geneva: International Labour Organization.
  • 7. National Health Insurance Service. A guideline for health examination, 2015. 2015, Seoul: National Health Insurance Service.
  • 8. D’Souza M. In: Bennett AE, editor. Early diagnosis and multiphasic screening. Recent advances in community medicine. 1978, London: Churchill; 194–214.
  • 9. Dobell H. Lectures on the germs and vestiges of disease: and on the prevention of the invasion and fatality of disease by periodical examinations; delivered at the royal infirmary for diseases of the chest. 1861, London: John Churchill.
  • 10. Holland W. Periodic health examination: history and critical assessment. Eurohealth 2010;15:16–20.
  • 11. Gould GM. A system of personal biologic examinations the condition of adequate medical and scientific conduct of life. JAMA 1900;XXXV:134–8. 10.1001/jama.1900.24620290004002.Article
  • 12. Seo HG. Periodic health examination in its historical perspectives. Uisahak 1999;8:79–89. 11624466.PubMed
  • 13. Holland WW, Stewart S. Screening in disease prevention: what works?. 2005, Oxford: Radcliffe Medical Press.
  • 14. Charap MH. The periodic health examination: genesis of a myth. Ann Intern Med 1981;95:733–5. 10.7326/0003-4819-95-6-733. 7030166.ArticlePubMed
  • 15. Breslow L, Roberts DW. Introductory statement on screening for asymptomatic disease. J Chronic Dis 1955;2:363–6. 10.1016/0021-9681(55)90176-4.Article
  • 16. Emerson H. Periodic medical examinations of apparently healthy persons. JAMA 1923;80:1376–81. 10.1001/jama.1923.26430460003011.Article
  • 17. Han PK. Historical changes in the objectives of the periodic health examination. Ann Intern Med 1997;127:910–7. 10.7326/0003-4819-127-10-199711150-00010. 9382370.ArticlePubMed
  • 18. Canadian Task Force on the Periodic Health Examination. The periodic health examination. Can Med Assoc J 1980;122:163.
  • 19. U.S. Preventive Services Task Force. Guide to clinical preventive services: report of the US Preventive Services Task Force. 1989, Collingdale: DIANE Publishing Co.
  • 20. U.S. Preventive Services Task Force. Guide to clinical preventive services: report of the US Preventive Services Task Force. 1996, Philadelphia: Lippincott Williams & Wilkins.
  • 21. Kim MH, Park YK, Park YA, Cho HJ. How has health examination become an “industry”?. 2015, Seoul: People’s Health Institute.
  • 22. Ministry of Employment and Labor. A study on the actual condition and challenges of workers’ general health examination follow-up management. 2011, Sejong: Ministry of Employment and Labor.
  • 23. Song YJ. The South Korean health care system. Jpn Med Assoc J 2009;52:206–9.
  • 24. Choi EJ, Kim DJ, Lee WC, Hwang IY. A plan to establish an efficient administration system focusing on customers for the improvement of national general health screening results. 2009, Seoul: Korea Institute for Health and Social Affairs.
  • 25. Yum YT. The last fifty years of western medicine in Korea - The Korean Society of Occupational Medicine. J Korean Med Assoc 1997;40:1118–21. 10.5124/jkma.1997.40.8.1118.Article
  • 26. st.
  • 27.
  • 28. http://www.moleg.go.kr/english/korLawEng?pstSeq=47517.
  • 29. Birtwhistle R, Pottie K, Shaw E, Dickinson JA, Brauer P, Fortin M, et al. Canadian task force on preventive health care: We’re back! Can Fam Physician 2012;58:13–5. 22267610.PubMedPMC
  • 30. http://www.moleg.go.kr/english/korLawEng?pstSeq=52989.
  • 31.
  • 32. Ministry of Health and Welfare. A study on the effect of national general health screening and ways of improvement: a report of the ministry of health and welfare on health improvement and research services. 2011, Seoul: Ministry of Health and Welfare.
  • 33. National Health Insurance Service. The effect of national general health examination on early detection of disease, use of medical service and health condition. 2011, Seoul: National Health Insurance Service.
  • 34.
  • 35. Kim DS, Kang SK. Work-related cerebro-cardiovascular diseases in Korea. J Korean Med Sci 2010;25:S105–11. 10.3346/jkms.2010.25.S.S105. 21258582.ArticlePubMedPMC
  • 36. Cha SH, Park HS, Cho HJ. Socioeconomic disparities in prevalence, treatment, and control of hypertension in middle-aged Koreans. J Epidemiol 2012;22:425–32. 10.2188/jea.JE20110132. 22785247.ArticlePubMedPMC
  • 37. Rabi DM, Edwards AL, Southern DA, Svenson LW, Sargious PM, Norton P, et al. Association of socio-economic status with diabetes prevalence and utilization of diabetes care services. BMC Health Serv Res 2006;6:124. 10.1186/1472-6963-6-124. 17018153.ArticlePubMedPMCPDF
  • 38. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 1993;88:1973–98. 10.1161/01.CIR.88.4.1973. 8403348.ArticlePubMed
  • 39. Ministry of Employment and Labor. A report of the actual working conditions depending on employment types. 2015, Sejong: Ministry of Employment and Labor.
  • 40. Cho BL, Lee CM. Current situation of national health screening systems in Korea. J Korean Med Assoc 2011;54:666–9. 10.5124/jkma.2011.54.7.666.Article
  • 41.
  • 42. Cho BL. An evaluation of the validity of the current national general health screening program and ways of system improvement. 2013, Osong: Korea Centers for Disease Control and Prevention.
  • 43. Berlin A, Yodaiken R, Logan D. International seminar on the assessment of toxic agents at the workplace roles of ambient and biological monitoring, Luxembourg, 8–12 December, 1980. Summary report. Int Arch Occup Environ Health 1982;50:197–207. 10.1007/BF00378081. 6126437.PubMed

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Risk of Cardiovascular Disease according to Baseline Low-Density Lipoprotein Cholesterol Level in Different Age Groups in Korean Diabetes Population: A Cohort Study
      Tae Kyung Yoo, Kyung-Do Han, Eun-Jung Rhee, Won-Young Lee
      Diabetes & Metabolism Journal.2024; 48(2): 265.     CrossRef
    • Altered Risk of Incident Gout According to Changes in Metabolic Syndrome Status: A Nationwide, Population‐Based Cohort Study of 1.29 Million Young Men
      Yeonghee Eun, Kyungdo Han, Seung Woo Lee, Kyunga Kim, Seonyoung Kang, Seulkee Lee, Hoon‐Suk Cha, Eun‐Mi Koh, Hyungjin Kim, Jaejoon Lee
      Arthritis & Rheumatology.2023; 75(5): 806.     CrossRef
    • Association with Combined Occupational Hazards Exposure and Risk of Metabolic Syndrome: A Workers' Health Examination Cohort 2012–2021
      Dongmug Kang, Eun-Soo Lee, Tae-Kyoung Kim, Yoon-Ji Kim, Seungho Lee, Woojoo Lee, Hyunman Sim, Se-Yeong Kim
      Safety and Health at Work.2023; 14(3): 279.     CrossRef
    • Increased risk of incident gout in young men with metabolic syndrome: A nationwide population-based cohort study of 3.5 million men
      Yeonghee Eun, Kyungdo Han, Seung Woo Lee, Kyunga Kim, Seonyoung Kang, Seulkee Lee, Hoon-Suk Cha, Eun-Mi Koh, Hyungjin Kim, Jaejoon Lee
      Frontiers in Medicine.2022;[Epub]     CrossRef
    • Alcohol use during pregnancy: findings from a gender-based violence survey in Mongolia
      Bolormaa Erdenetuya, Dayoon Kwon, Sugy Choi, Seung-Ah Choe
      Archives of Women's Mental Health.2022; 25(4): 789.     CrossRef
    • National General Health Screening Program in Korea: history, current status, and future direction
      Dong Wook Shin, Juhee Cho, Jae Hyun Park, BeLong Cho
      Precision and Future Medicine.2022; 6(1): 9.     CrossRef
    • Development of a Chatbot Program for Follow-Up Management of Workers’ General Health Examinations in Korea: A Pilot Study
      Byeong Jin Ye, Ju Young Kim, Chunhui Suh, Seong Pil Choi, Maro Choi, Dong Hyun Kim, Byung Chul Son
      International Journal of Environmental Research and Public Health.2021; 18(4): 2170.     CrossRef
    • Reliability and Validity of a Nationwide Survey (the Korean Radiation Workers Study)
      Dalnim Lee, Wan Young Lim, Soojin Park, Young Woo Jin, Won Jin Lee, Sunhoo Park, Songwon Seo
      Safety and Health at Work.2021; 12(4): 445.     CrossRef
    • Evaluation of occupational noise exposure and general health of workers in industrial sites: A case study
      Kamal Ebrahimi, Reza Tajik, Taybeh Karami, Samira Rahimnejad, Farshad Arghavani
      Work.2021; 68(1): 115.     CrossRef
    • Occupational health nurses’ personal attitudes toward smoking: A cross-sectional study
      Jihye Lee, Saerom Lee, Minkyu Lee, Young Joong Kang
      Journal of Occupational Health.2021;[Epub]     CrossRef
    • Urinary bisphenol A, phthalate metabolites, and obesity: do gender and menopausal status matter?
      Jung-eun Lim, BongKyoo Choi, Sun Ha Jee
      Environmental Science and Pollution Research.2020; 27(27): 34300.     CrossRef
    • A Cohort Study of Korean Radiation Workers: Baseline Characteristics of Participants
      Soojin Park, Songwon Seo, Dalnim Lee, Sunhoo Park, Young Woo Jin
      International Journal of Environmental Research and Public Health.2020; 17(7): 2328.     CrossRef
    • The cumulative incidence and trends of rare diseases in South Korea: a nationwide study of the administrative data from the National Health Insurance Service database from 2011–2015
      Sung-Shil Lim, Wanhyung Lee, Yeong-Kwang Kim, Jihyun Kim, Jong Heon Park, Bo Ram Park, Jin-Ha Yoon
      Orphanet Journal of Rare Diseases.2019;[Epub]     CrossRef
    • Disparities in the utilisation of preventive health services by the employment status: An analysis of 2007-2012 South Korean national survey
      SangJune Kim, Jee Hey Song, Yoo Min Oh, Sang Min Park, Geofrey Musinguzi
      PLOS ONE.2018; 13(12): e0207737.     CrossRef
    • The Relationship between Workplace Environment and Metabolic Syndrome
      Hwee-Soo Jeong
      The International Journal of Occupational and Environmental Medicine.2018; 9(4): 176.     CrossRef
    • Erratum to: The current condition of the workers’ general health examination in South Korea: a retrospective study
      Young Joong Kang, Jun-Pyo Myong, Huisu Eom, Bowha Choi, Jong Heon Park, Eun-A L Kim
      Annals of Occupational and Environmental Medicine.2017;[Epub]     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      The current condition of the workers’ general health examination in South Korea: a retrospective study
      Ann Occup Environ Med. 2017;29:6  Published online March 7, 2017
      Close
    • XML DownloadXML Download
    Figure
    • 0
    The current condition of the workers’ general health examination in South Korea: a retrospective study
    Image
    Fig. 1 Changes in participation rates and the prevalence of diabetes and hypertension. Note: DM, diabetes; HTN, hypertension
    The current condition of the workers’ general health examination in South Korea: a retrospective study
    2006200720082009
    TSa (N)Pb (n, %)TS (N)P (n, %)TS (N)P (n, %)TS (N)P (n, %)
    Overall participation rate15,053,7618,408,218(56%)14,358,7098,419,532(59%)16,493,80110,264,420(62%)16,277,23910,537,866(65%)
    National health insurance type
    Workplace policyholder
      Non-public worker6,138,5664,756,163(77%)6,172,5565,016,210(81%)7,411,5105,953,473(80%)7,625,1086,290,437(82%)
      Office worker1,515,5231,078,249(71%)1,072,442839,517(78%)2782,1762,044,152(73%)2,732,1742,049,755(75%)
     Non-office worker4,623,0433,677,914(80%)5,100,1144,176,693(82%)4,629,3343,909,321(84%)4,892,9344,240,682(87%)
     Public official924,071771,830(84%)278,547213,526(77%)900,087779,838(87%)240,178195,910(82%)
     Dependents2,915,8631,383,217(47%)3,137,6261,646,793(52%)3,380,9981,831,665(54%)3,760,9712,216,809(59%)
    Regional policyholder
     Householder3,422,767881,827(26%)3,230,823920,406(28%)3,252,3551,023,396(31%)3,131,6561,113,517(36%)
     Household member1,652,494615,181(37%)1,539,157622,597(40%)1,548,851676,048(44%)1,519,326721,193(47%)
    Enterprise size (no. of employees)
      ≥ 3003,919,0212,825,502(72%)3,623,5232,663,471(74%)4,210,3293,195,498(76%)4,032,0243,119,928(77%)
     50–2992,518,8521,905,700(76%)2,299,0551,768,735(77%)2,803,2982,235,709(80%)2,665,9652,125,705(80%)
      < 503,540,5762,179,986(62%)3,664,9982,443,371(67%)4,678,8823,133,715(67%)4,927,3733,456,632(70%)
    Sex
     Male8,345,1244,858,065(58%)7,856,9874,833,287(62%)8,992,9655,763,063(64%)8,762,2425,816,276(66%)
     Female6,708,6373,550,153(53%)6,501,7223,586,245(55%)7,500,8364,501,357(60%)7,514,9974,721,590(63%)
    Age
     20s1,549,8901,188,441(77%)1,457,1741,199,391(82%)1,755,3911,413,162(81%)1,599,9161,305,813(82%)
     30s2,989,4881,874,052(63%)2,652,8071,764,649(67%)3,167,6562,170,990(69%)2,883,7612,014,012(70%)
     40s4,556,4262,252,394(49%)4,256,3962,156,367(51%)4,796,8022,677,379(56%)4,652,7572,744,518(59%)
     50s2,891,2511,608,651(56%)2,826,5861,620,394(57%)3,303,8622,067,020(63%)3,443,7632,235,227(65%)
     60s1,795,284984,003(55%)1,839,1831,081,039(59%)2,016,0841,260,900(63%)2,097,1981,421,468(68%)
     70s961,201426,452(44%)1,002,204504,698(50%)1,099,354575,863(52%)1,202,184692,595(58%)
     80s259,01556,875(22%)276,87177,305(28%)302,44482,816(27%)339,723104,206(31%)
     90s32,1352,142(7%)31,6293,063(10%)35,8673,276(9%)39,7744,676(12%)
    2010201120122013
    TS (N)P (n, %)TS (N)P (n, %)TS (N)P (n, %)TS (N)P (n, %)
    Overall participation rate17,039,77411,491,730(67%)16,333,46411,739,774(72%)16,731,04012,083,276(72%)16,911,46412,108,885(72%)
    National health insurance type
    Workplace policyholder
     Non-public worker7,707,0496,414,938(83%)7,989,6906,745,581(84%)8,018,9336,578,513(82%)8,408,3486,952,209(83%)
      Office worker2,816,3432,088,031(74%)3,061,5142,302,668(75%)2,975,5922,120,013(71%)3,042,0022,091,641(69%)
      Non-office worker4,890,7064,326,907(88%)4,928,1764,442,913(90%)5,043,3414,458,500(88%)5,366,3464,860,568(91%)
     Public official689,527606,349(88%)296,912250,506(84%)638,023569,189(89%)325,082281,320(87%)
     Dependents3,839,5172,318,688(60%)3,684,6032,444,912(66%)3,722,1322,444,875(66%)3,860,9062,563,906(66%)
    Regional policyholder
     Householder3,264,5891,350,573(41%)2,910,9731,440,608(49%)2,895,7811,568,840(54%)2,870,9201,462,230(51%)
     Household member1,539,092801,182(52%)1,451,286858,167(59%)1,456,171921,859(63%)1,446,208849,220(59%)
    Enterprise size (no. of employees)
      ≥ 3004,467,4233,546,046(79%)4,258,7403,482,842(82%)4,628,5763,786,158(82%)4,549,0443,748,268(82%)
     50–2992,893,5942,371,029(82%)2,694,6422,268,129(84%)2,927,2942,455,925(84%)2,845,0162,400,555(84%)
      < 504,874,6793,422,505(70%)5,017,2363,689,450(74%)4,823,1023,350,385(69%)5,176,5263,625,079(70%)
    Sex
     Male9,201,7256,323,006(69%)8,814,4746,443,675(73%)8,985,4166,603,480(73%)9,049,4556,613,771(73%)
     Female7,838,0495,168,724(66%)7,518,9905,296,099(70%)7,745,6245,479,796(71%)7,862,0095,495,114(70%)
    Age
     20s1,495,9711,232,87982%)1,464,2871,245,499(85%)1,361,2091,147,620(84%)1,260,8881,062,788(84%)
     30s3,075,0012,240,262(73%)2,897,3692,213,257(76%)2,933,7312,250,399(77%)2,764,8692,143,148(78%)
     40s4,791,9943,017,490(63%)4,516,1713,071,894(68%)4,525,2053,110,001(69%)4,684,6053,206,437(68%)
     50s3,859,1382,598,385(67%)3,757,9462,710,203(72%)3,986,8892,895,631(73%)4,080,0432,896,439(71%)
     60s2,140,2551,513,228(71%)2,000,6311,517,664(76%)2,123,3431,610,092(76%)2,224,2831,681,885(76%)
     70s1,245,070746,457(60%)1,263,309815,426(65%)1,344,136885,701(66%)1,394,240917,989(66%)
     80s366,394118,893(32%)364,581136,226(37%)380,969149,655(39%)427,317172,632(40%)
     90s44,8506,122(14%)45,0307,667(17%)47,3518,336(18%)56,21411,183(20%)
    2006200720082009
    TSa (N)Pb (n, %)TS (N)P (n, %)TS (N)P (n, %)TS (N)P (n, %)
    Overall participation rate1,528,258542,159(35%)1,510,570494,307(33%)1,685,419613,629(36%)1,338,668531,368(40%)
    National health insurance type
    Workplace policyholder
     Non-public worker653,174322,341(49%)665,972302,288(45%)762,107349,892(46%)770,863353,721(46%)
     Public official101,16130,023(30%)32,5398,961(28%)88,98528,977(33%)24,1407,742(32%)
     Dependents391,37097,262(25%)442,65797,755(22%)454,519124,020(27%)183,43258,923(32%)
    Regional policyholder
     Householder243,23159,889(25%)238,32756,214(24%)246,34373,685(30%)236,90174,466(31%)
     Household member139,32232,644(23%)131,07529,089(22%)133,46537,055(28%)123,33236,516(30%)
    Enterprise size (no. of employees)
      ≥ 300275,350136,199(49%)225,949112,065(50%)268,608129,066(48%)219,811113,998(52%)
     50–299219,415115,623(53%)197,555101,858(52%)235,050121,476(52%)209,477115,495(55%)
      < 50269,550104,625(39%)289,385102,813(36%)358,311133,238(37%)377,482137,729(36%)
    Sex
     Male978,849389,925(40%)946,445352,068(37%)1,073,130427,195(40%)1,018,462419,269(41%)
     Female549,409152,234(28%)564,125142,239(25%)612,289186,434(30%)320,206112,099(35%)
    Age
     20s53,69229,402(55%)53,88128,447(53%)59,13731,297(53%)51,07725,389(50%)
     30s182,01887,805(48%)174,08582,411(47%)200,58094,595(47%)173,04079,718(46%)
     40s349,126140,327(40%)320,442115,845(36%)399,238148,974(37%)326,432135,562(42%)
     50s399,951144,490(36%)381,998137,387(36%)488,436189,839(39%)392,327154,592(39%)
     60s343,32597,380(28%)353,61884,869(24%)355,684102,449(29%)349,726125,906(36%)
     70s173,63038,075(22%)192,74240,215(21%)157,25141,561(26%)233,23571,208(31%)
     80s25,2384,363(17%)32,2304,844(15%)23,5414,619(20%)92,78422,048(24%)
     90s1,026149(15%)1,327138(10%)1,295172(13%)13,9372,607(19%)
    2010201120122013
    TS (N)P (n, %)TS (N)P (n, %)TS (N)P (n, %)TS (N)P (n, %)
    Overall participation rate1,013,976414,029(41%)997,658372,073(37%)1,154,033429,375(37%)1,078,029390,170(36%)
    National health insurance type
    Workplace policyholder
     Non-public worker597,762280,244(47%)607,131265,565(44%)576,320267,880(46%)571,016249,827(44%)
     Public official46,35414,505(31%)22,1125,313(24%)44,78912,177(27%)21,6505,225(24%)
     Dependents114,74138,049(33%)110,15031,263(28%)256,00273,162(29%)247,98169,859(28%)
    Regional policyholder
     Householder175,33256,573(32%)177,09048,673(27%)190,65452,647(28%)164,15545,594(28%)
     Household member79,78724,658(31%)81,17521,259(26%)86,26823,509(27%)73,22719,665(27%)
    Enterprise size (no. of employees)
      ≥ 300206,469103,135(50%)189,16394,346(50%)210,284104,726(50%)189,63496,030(51%)
     50–299174,35194,622(54%)163,76787,370(53%)173,68792,500(53%)159,20981,765(51%)
      < 50270,05599,992(37%)281,23091,208(32%)239,64284,064(35%)245,45278,007(32%)
    Sex
     Male797,375336,353(42%)784,090304,117(39%)789,236317,283(40%)733,806286,863(39%)
     Female216,60177,676(36%)213,56867,956(32%)364,797112,092(31%)344,223103,307(30%)
    Age
     20s42,00121,505(51%)41,11619,830(48%)36,47017,710(49%)30,38513,873(46%)
     30s160,82074,726(46%)162,10170,814(44%)155,70971,811(46%)137,90861,367(44%)
     40s303,173122,650(40%)306,178112,285(37%)303,601116,296(38%)288,295104,637(36%)
     50s332,857133,182(40%)331,139120,083(36%)341,649129,235(38%)316,123117,016(37%)
     60s208,22077,363(37%)190,03461,912(33%)190,89965,006(34%)184,23763,703(35%)
     70s102,76228,613(28%)99,10024,670(25%)104,07726,562(26%)98,09526,123(27%)
     80s17,9253,388(19%)18,0352,988(17%)19,8292,424(12%)20,9173,141(15%)
     90s1,093141(13%)1,261157(12%)1,36290(7%)1,762183(10%)
    20052006
    DMHTNDiabetesHypertension
    Total subjects(N)Cases (N,%)Cases (N,%)Total (N)Cases (n, %)Cases (n, %)
    Total prevalence
    6,399,291190,937(3%)462,760(7%)8,408,218261,2163.11%(3%)668,2777.9%(8%)
    Nation health insurance type
     Regional policyholder + dependents2,305,435134,744(6%)349,530(15%)2,880,225179,9506.25%(6%)484,16416.8%(17%)
     Non-public worker
      Office worker687,5228,630(1%)15,481(2%)1,078,24915,4531.43%(1%)32,5843.0%(3%)
      Non-office worker3,251,60944,261(1%)91,635(3%)3,677,91451,8621.41%(1%)118,4293.2%(3%)
     Public official154,7253,302(2%)6,114(4%)771,83013,9511.81%(2%)33,1004.3%(4%)
    Enterprise size
      ≥ 3002,044,94548,381(2%)114,524(6%)2,825,50269,9462.48%(2%)176,5576.25%(6%)
     50–2991,387,05133,339(2%)78,854(6%)1,905,70046,3422.43%(2%)117,6966.18%(6%)
      < 501,749,38145,211(3%)110,543(6%)2,179,98659,9082.75%(3%)154,4467.08%(7%)
     Missing1,217,91464,006158,8391,497,03085,0205.68%219,57814.67%
    Sex
     Male3,767,406108,226(3%)216,368(6%)4,858,065147,8423.04%(3%)318,6066.56%(7%)
     Female2,631,88582,711(3%)246,392(9%)3,550,153113,3743.19%(3%)349,6719.85%(10%)
    Age
     20s927,5321,864(0%)1,671(0%)1,188,4412,1790.18%(0%)2,1850.18%(0%)
     30s1,450,6468,309(1%)11,403(1%)1,874,0529,6630.52%(1%)15,9520.85%(1%)
     40s1,682,74330,054(2%)60,911(4%)2,252,39439,6241.76%(2%)90,1484.00%(4%)
     50s1,187,31452,803(4%)128,562(11%)1,608,65173,7934.59%(5%)189,49611.78%(12%)
     60s778,42264,175(8%)159,391(20%)984,00386,9398.84%(9%)222,10022.57%(23%)
     70s313,96830,304(10%)87,743(28%)426,45244,23310.37%(10%)129,94130.47%(30%)
     80s44,9333,344(7%)12,732(28%)56,8754,6828.23%(8%)17,92231.51%(32%)
     90s1,58763(4%)339(21%)2,142763.55%(4%)52524.51%(25%)
     Missing12,14612,14612,14615,208278
    20072008
    DiabetesHypertensionDiabetesHypertension
    Total (N)Cases (n,%)Cases (n,%)Total (N)Cases (n,%)Cases (n,%)
    Total prevalence
    8,419,532265,8133.16%(3%)708,6478.42%(8%)10,264,420331,8933.23%(3%)900,0568.77%(9%)
    Nation health insurance type
     Regional policyholder + dependents3,189,796190,8085.98%(6%)528,42816.57%(17%)3,531,109221,5816.28%(6%)619,03817.53%(18%)
     Non-public worker
      Office worker839,51710,0551.20%(1%)21,1772.52%(3%)2,044,15232,1261.57%(2%)77,5713.79%(4%)
      Non-office worker4,176,69360,6941.45%(1%)149,5953.58%(4%)3,909,32163,2171.62%(2%)164,4004.21%(4%)
     Public official213,5264,2561.99%(2%)9,4474.42%(4%)779,83814,9691.92%(2%)39,0475.01%(5%)
    Enterprise size
      ≥ 3002,663,47168,5772.57%(3%)183,1486.88%(7%)3,195,49886,9212.72%(3%)235,1007.36%(7%)
     50–2991,768,73546,5862.63%(3%)121,7956.89%(7%)2,235,70959,4102.66%(3%)161,7787.24%(7%)
      < 502,443,37167,3162.76%(3%)182,8387.48%(7%)3,133,71590,0222.87%(3%)247,5607.90%(8%)
     missing1,543,95583,3345.40%220,86614.31%1,699,49895,5405.62%255,61815.04%
    Sex
     Male4,833,287146,7823.04%(3%)328,6196.80%(7%)5,763,063188,6713.27%(3%)435,4317.56%(8%)
     Female3,586,245119,0313.32%(3%)380,02810.60%(11%)4,501,357143,2223.18%(3%)464,62510.32%(10%)
    Age
     20s1,199,3911,9190.16%(0%)2,2640.19%(0%)1,413,1622,0860.15%(0%)2,9050.21%(0%)
     30s1,764,6499,1320.52%(1%)16,1150.91%(1%)2,170,99010,8240.50%(0%)21,5030.99%(1%)
     40s2,156,36735,1671.63%(2%)84,6473.93%(4%)2,677,37945,0851.68%(2%)113,8284.25%(4%)
     50s1,620,39475,8994.68%(5%)200,59612.38%(12%)2,067,020101,6334.92%(5%)273,74213.24%(13%)
     60s1,081,03981,4707.54%(8%)214,58619.85%(20%)1,260,90093,8297.44%(7%)251,24519.93%(20%)
     70s504,69855,26710.95%(11%)163,28532.35%(32%)575,86370,02812.16%(12%)204,29335.48%(35%)
     80s77,3056,8058.80%(9%)26,29434.01%(34%)82,8168,2149.92%(10%)31,49138.03%(38%)
     90s3,0631404.57%(5%)85027.75%(28%)3,2761755.34%(5%)1,04331.84%(32%)
     Missing12,626141013,014196
    20092010
    DiabetesHypertensionDiabetesHypertension
    Total (n)Cases (n, %)Cases (n, %)Total (n)Cases (n, %)Cases (n, %)
    Total prevalence
    10,537,866535,9045.09%(5%)1,481,62314.06%(14%)11,491,730612,9765.33%(5%)1,762,19015.33%(15%)
    Nation health insurance type
     Regional policyholder + dependents4,051,519345,1258.52%(9%)971,68723.98%(24%)4,470,443411,4059.20%(9%)1,164,12626.04%(26%)
     Non-public worker
      Office worker2,049,75556,0982.74%(3%)155,5027.59%(8%)2,088,03163,9983.06%(3%)177,6688.51%(9%)
      Non-office worker4,240,682129,3583.05%(3%)340,1938.02%(8%)4,326,907122,1662.82%(3%)373,4748.63%(9%)
     Public official195,9105,3232.72%(3%)14,2417.27%(7%)606,34915,4072.54%(3%)46,9227.74%(8%)
    Enterprise size
      ≥ 3003,119,928153,0874.91%(5%)397,56212.74%(13%)3,546,046162,4484.58%(5%)466,60013.16%(13%)
     50–2992,125,70588,3214.15%(4%)259,23912.20%(12%)2,371,029104,5844.41%(4%)314,65613.27%(13%)
      < 503,456,632157,4024.55%(5%)454,65813.15%(13%)3,422,505172,8565.05%(5%)509,23214.88%(15%)
     Missing1,835,601137,0947.47%370,16420.17%2,152,150173,0888.04%471,70221.92%
    Sex
     Male5,816,276308,5195.30%(5%)742,50712.77%(13%)6,323,006352,8915.58%(6%)907,36714.35%(14%)
     Female4,721,590227,3854.82%(5%)739,11615.65%(16%)5,168,724260,0855.03%(5%)854,82316.54%(17%)
    Age
     20s1,305,8133,0150.23%(0%)10,0250.77%(1%)1,232,8792,0550.17%(0%)8,4770.69%(1%)
     30s2,014,01218,1800.90%(1%)46,2422.30%(2%)2,240,26216,9260.76%(1%)48,7912.18%(2%)
     40s2,744,51882,7763.02%(3%)198,8937.25%(7%)3,017,49081,2542.69%(3%)220,4627.31%(7%)
     50s2,235,227146,5466.56%(7%)407,90018.25%(18%)2,598,385176,6866.80%(7%)513,78319.77%(20%)
     60s1,421,468170,97112.03%(12%)471,27733.15%(33%)1,513,228197,63313.06%(13%)553,20336.56%(37%)
     70s692,595101,39314.64%(15%)297,95843.02%(43%)746,457121,67116.30%(16%)354,56447.50%(47%)
     80s104,20612,65912.15%(12%)47,41445.50%(46%)118,89316,23813.66%(14%)60,17650.61%(51%)
     90s4,6763387.23%(7%)1,84339.41%(39%)6,1224797.82%(8%)2,64843.25%(43%)
     Missing15,351267118,0143486
    201120122013
    DiabetesHypertensionDiabetesHypertensionDiabetesHypertension
    Total (N)Cases (n, %)Cases (n, %)Total (N)Cases (n, %)Cases (n, %)Total (N)Cases (n, %)Cases (n, %)
    Total prevalence
    11,739,774660,1735.62%(6%)1,894,83516.14%(16%)12,083,276720,7855.97%(6%)2,036,24916.85%(17%)12,108,885752,4796.21%(6%)2,092,68217.28%(17%)
    Nation health insurance type
     Regional policyholder + dependents4,743,687453,7719.57%(10%)1,268,58026.74%(27%)4,935,574500,27610.14%(10%)1,366,09827.68%(28%)4,875,356516,19610.59%(11%)1,392,42728.56%(29%)
     Non-public worker
      Office worker2,302,66867,6562.94%(3%)191,3648.31%(8%)2,120,01367,6363.19%(3%)192,5179.08%(9%)2,091,64166,3763.17%(3%)182,8378.74%(9%)
      Non-office worker4,442,913130,8952.95%(3%)413,8799.32%(9%)4,458,500135,2183.03%(3%)425,4819.54%(10%)4,860,568160,7623.31%(3%)492,73110.14%(10%)
     Public official250,5067,8513.13%(3%)21,0128.39%(8%)569,18917,6553.10%(3%)52,1539.16%(9%)281,3209,1453.25%(3%)24,6878.78%(9%)
    Enterprise size
      ≥ 3003,482,842163,1774.69%(5%)486,09913.96%(14%)3,786,158185,9874.91%(5%)543,38414.35%(14%)3,748,268190,6275.09%(5%)548,14714.62%(15%)
     50–2992,268,129110,3184.86%(5%)326,98514.42%(14%)2,455,925123,2255.02%(5%)360,71314.69%(15%)2,400,555128,6155.36%(5%)367,92815.33%(15%)
      < 503,689,450193,9745.26%(5%)564,87515.31%(15%)3,350,385189,9175.67%(6%)553,20016.51%(17%)3,625,079215,4835.94%(6%)610,82916.85%(17%)
     Missing2,299,353192,7048.38%516,87622.48%2,490,808221,6568.90%578,95223.24%2,334,983217,7549.33%565,77824.23%
    Sex
     Male6,443,675375,5315.83%(6%)972,05315.09%(15%)6,603,480414,2076.27%(6%)1,064,97016.13%(16%)6,613,771430,8306.51%(7%)1,092,63216.52%(17%)
     Female5,296,099284,6425.37%(5%)922,78217.42%(17%)5,479,796306,5785.59%(6%)971,27917.72%(18%)5,495,114321,6495.85%(6%)1,000,05018.20%(18%)
    Age
     20s1,245,4992,0720.17%(0%)8,7130.70%(1%)1,147,6201,9080.17%(0%)7,6480.67%(1%)1,062,7881,8370.17%(0%)6,9640.66%(1%)
     30s2,213,25715,5260.70%(1%)51,5802.33%(2%)2,250,39915,7100.70%(1%)50,2312.23%(2%)2,143,14813,7300.64%(1%)45,1072.10%(2%)
     40s3,071,89482,0472.67%(3%)229,0487.46%(7%)3,110,00185,9782.76%(3%)238,1807.66%(8%)3,206,43787,1442.72%(3%)235,8127.35%(7%)
     50s2,710,203190,6517.03%(7%)550,82920.32%(20%)2,895,631206,7817.14%(7%)591,90220.44%(20%)2,896,439208,2417.19%(7%)587,06320.27%(20%)
     60s1,517,664207,08213.64%(14%)572,46637.72%(38%)1,610,092223,86013.90%(14%)610,74937.93%(38%)1,681,885238,41314.18%(14%)638,45537.96%(38%)
     70s815,426141,38417.34%(17%)405,29849.70%(50%)885,701161,24418.21%(18%)449,97050.80%(51%)917,989172,33418.77%(19%)475,13951.76%(52%)
     80s136,22620,67915.18%(15%)73,26753.78%(54%)149,65524,36916.28%(16%)83,41155.74%(56%)172,63229,53017.11%(17%)98,32056.95%(57%)
     90s7,6676878.96%(9%)3,52345.95%(46%)8,33687410.48%(10%)4,04748.55%(49%)11,1831,22010.91%(11%)5,74951.41%(51%)
     Missing21,9384511125,8416111116,3843073
    DiabetesHypertension
    40s50s40s50s
    Year Enterprise size (no. of employees)OR95% CIOR95% CIOR95% CIOR95% CI
    2006
      ≥ 3001.0 (ref)1.0 (ref)1.0 (ref)1.0 (ref)
     50 ~ 2991.071(1.04 – 1.102)1.022(0.999 – 1.045)1.093(1.071 – 1.114)1.041(1.026 – 1.057)
      < 501.204(1.171 – 1.238)1.07(1.046 – 1.093)1.259(1.236 – 1.283)1.108(1.092 – 1.124)
    2007
      ≥ 3001.0 (ref)1.0 (ref)1.0 (ref)1.0 (ref)
     50 ~ 2991.169(1.132 – 1.207)1.107(1.082 – 1.133)1.163(1.138 – 1.188)1.062(1.046 – 1.078)
      < 501.253(1.216 – 1.29)1.129(1.105 – 1.153)1.346(1.321 – 1.373)1.155(1.14 – 1.171)
    2008
      ≥ 3001.0 (ref)1.0 (ref)1.0 (ref)1.0 (ref)
     50 ~ 2991.041(1.012 – 1.071)1.036(1.016 – 1.057)1.107(1.088 – 1.127)1.036(1.024 – 1.049)
      < 501.168(1.138 – 1.199)1.074(1.055 – 1.094)1.264(1.243 – 1.285)1.116(1.103 – 1.129)
    2009
      ≥ 3001.0 (ref)1.0 (ref)1.0 (ref)1.0 (ref)
     50 ~ 2990.555(0.543 – 0.567)0.955(0.939 – 0.971)0.837(0.826 – 0.849)1.011(1.001 – 1.022)
      < 500.615(0.604 – 0.627)0.976(0.962 – 0.991)0.898(0.887 – 0.909)1.052(1.042 – 1.062)
    2010
      ≥ 3001.0 (ref)1.0 (ref)1.0 (ref)1.0 (ref)
     50 ~ 2990.907(0.888 – 0.926)1.028(1.013 – 1.044)1.071(1.057 – 1.085)1.037(1.027 – 1.047)
      < 500.97(0.952 – 0.988)1.058(1.044 – 1.072)1.131(1.118 – 1.144)1.068(1.059 – 1.077)
    2011
      ≥ 3001.0 (ref)1.0 (ref)1.0 (ref)1.0 (ref)
     50 ~ 2991.124(1.121 – 1.128)1.097(1.095 – 1.099)1.085(1.071 – 1.099)1.065(1.055 – 1.075)
      < 502.535(2.483 – 2.588)1.996(1.971 – 2.022)1.114(1.102 – 1.127)1.078(1.069 – 1.088)
    2012
      ≥ 3001.0 (ref)1.0 (ref)1.0 (ref)1.0 (ref)
     50 ~ 2991.052(1.031 – 1.074)1.063(1.048 – 1.078)1.071(1.058 – 1.084)1.062(1.052 – 1.071)
      < 501.098(1.078 – 1.119)1.048(1.035 – 1.061)1.113(1.101 – 1.126)1.069(1.06 – 1.077)
    2013
      ≥ 3001.0 (ref)1.0 (ref)1.0 (ref)1.0 (ref)
     50 ~ 2991.047(1.026 – 1.069)1.109(1.093 – 1.125)1.063(1.05 – 1.076)1.087(1.077 – 1.096)
      < 501.082(1.063 – 1.102)1.082(1.068 – 1.096)1.087(1.075 – 1.1)1.092(1.083 – 1.101)
    Table 1 Participation rate in primary health examination

    aTS: Total subjects

    bP: Participants in health examination

    Table 2 Participation rates in secondary health examination

    aTS: Total subjects

    bP: Participants in health examination

    Table 3 Prevalence rates of diabetes and hypertension among study population

    Table 4 Odds ratios of diabetes and hypertension among workplace policyholders in their 40s and 50s by enterprise size (2006–2013)


    Ann Occup Environ Med : Annals of Occupational and Environmental Medicine
    Close layer
    TOP